Table quality_incentive_pool_qip_program_data_year_1

Table: quality_incentive_pool_qip_program_data_year_1

py type hospital number title report_status baseline_rate baseline_rate_annotation_code target_rate numerator numerator_annotation_code denominator denominator_annotation_code achievement_rate achievement_rate_annotation_code achievement_value

'PY1' 'DPH' 'Alameda Health System' 'Q-PC1' 'Comprehensive Diabetes Care: A1C Control (<8%%) (CDC-H8)' 'Reported' '0' '0' '0' '1476' '0' '2671' '0' '55.30%%' '0' '1'

'PY1' 'DPH' 'Alameda Health System' 'Q-PC2' 'Comprehensive Diabetes Care: Eye Exam (CDC-E)' 'Reported' '0' '0' '0' '1361' '0' '2671' '0' '51.00%%' '0' '1'

'PY1' 'DPH' 'Alameda Health System' 'Q-PC3' 'Comprehensive Diabetes Care: Blood Pressure Control (CDC-BP)' 'Reported' '0' '0' '0' '1943' '0' '2671' '0' '72.70%%' '0' '1'

'PY1' 'DPH' 'Alameda Health System' 'Q-PC4' 'Asthma Medication Ratio (AMR)' 'Reported' '0' '0' '0' '205' '0' '349' '0' '58.70%%' '0' '1'

'PY1' 'DPH' 'Alameda Health System' 'Q-PC5' 'Medication Reconciliation Post Discharge (MRP)' 'Reported' '0' '0' '0' '1038' '0' '2002' '0' '51.90%%' '0' '1'

'PY1' 'DPH' 'Alameda Health System' 'Q-PC6' '7 Day Post-Discharge Follow-Up for High Risk Beneficiaries' 'Reported' '0' '0' '0' '248' '0' '1026' '0' '24.20%%' '0' '1'

'PY1' 'DPH' 'Alameda Health System' 'Q-PC7' 'Children and Adolescent Access to PCP (CAP)' 'Reported' 'N/A' '3' 'N/A' '' '' '' '' '' '' '1'

'PY1' 'DPH' 'Alameda Health System' 'Q-PC7' '? 12-24 Months' 'Reported' '0' '0' '0' '366' '0' '409' '0' '89.50%%' '0' '1'

'PY1' 'DPH' 'Alameda Health System' 'Q-PC7' '? 25 Months-6 Years' 'Reported' '0' '0' '0' '1952' '0' '2547' '0' '76.60%%' '0' '1'

'PY1' 'DPH' 'Alameda Health System' 'Q-PC7' '? 7-11 Years' 'Reported' '0' '0' '0' '1547' '0' '1980' '0' '78.10%%' '0' '1'

'PY1' 'DPH' 'Alameda Health System' 'Q-PC7' '? 12-19 Years' 'Reported' '0' '0' '0' '1640' '0' '2338' '0' '70.20%%' '0' '1'

'PY1' 'DPH' 'Alameda Health System' 'Q-PC8' 'Childhood Immunization Status (CIS) Combination 3' 'Reported' '0' '0' '0' '332' '0' '401' '0' '82.80%%' '0' '1'

'PY1' 'DPH' 'Alameda Health System' 'Q-PC9' 'Immunization for Adolescents (IMA) Combination 2' 'Reported' '0' '0' '0' '143' '0' '232' '0' '61.60%%' '0' '1'

'PY1' 'DPH' 'Alameda Health System' 'Q-SC1' 'Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy' 'Reported' '0' '0' '0' '117' '0' '148' '0' '79.10%%' '0' '1'

'PY1' 'DPH' 'Alameda Health System' 'Q-SC2' 'Coronary Artery Disease (CAD): Antiplatelet Therapy' 'Reported' '0' '0' '0' '264' '0' '271' '0' '97.40%%' '0' '1'

'PY1' 'DPH' 'Alameda Health System' 'Q-SC3' 'Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%%)' 'Reported' '0' '0' '0' '316' '0' '341' '0' '92.70%%' '0' '1'

'PY1' 'DPH' 'Alameda Health System' 'Q-SC4' 'Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%%)' 'Reported' '0' '0' '0' '256' '0' '275' '0' '93.10%%' '0' '1'

'PY1' 'DPH' 'Alameda Health System' 'Q-SC5' 'Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction' 'Reported' '0' '0' '0' '140' '0' '150' '0' '93.30%%' '0' '1'

'PY1' 'DPH' 'Alameda Health System' 'Q-SC6' 'Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction' 'Reported' '0' '0' '0' '167' '0' '192' '0' '87.00%%' '0' '1'

'PY1' 'DPH' 'Alameda Health System' 'Q-IP1' 'Surgical Site Infection (SSI) (Reported as SIR)' 'Reported' '0' '0' '0' '' '1' '8.837' '0' '' '1' '1'

'PY1' 'DPH' 'Alameda Health System' 'Q-IP2' 'Perioperative Care: Selection of Prophylactic Antibiotic - 1st OR 2nd Generation Cephalosporin' 'Reported' '0' '0' '0' '321' '0' '323' '0' '99.40%%' '0' '1'

'PY1' 'DPH' 'Alameda Health System' 'Q-IP3' 'Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis' 'Reported' '0' '0' '0' '323' '0' '323' '0' '100.00%%' '0' '1'

'PY1' 'DPH' 'Alameda Health System' 'Q-IP4' 'Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections' 'Reported' '0' '0' '0' '51' '0' '1370' '0' '3.70%%' '0' '1'

'PY1' 'DPH' 'Alameda Health System' 'Q-IP5' 'Appropriate Treatment of Methicillin-Sensitive Staphylococcus Aureus (MSSA) Bacteremia' 'Reported' '0' '0' '0' '39' '0' '47' '0' '83.00%%' '0' '1'

'PY1' 'DPH' 'Alameda Health System' 'Q-IP6' 'Stroke: Discharged on Antithrombotic Therapy (TJC STK-2)' 'Reported' '0' '0' '0' '61' '0' '98' '0' '62.20%%' '0' '1'

'PY1' 'DPH' 'Alameda Health System' 'Q-RU1' 'Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low Risk Surgery Patients (QPP)' 'Reported' '0' '0' '0' '0' '0' '292' '0' '0.00%%' '0' '1'

'PY1' 'DPH' 'Alameda Health System' 'Q-RU2' 'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients 18 Years and Older' 'Not Reported' '' '' '' ' ' '' ' ' '' ' ' '' ''

'PY1' 'DPH' 'Alameda Health System' 'Q-RU3' 'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 to 17 years old' 'Not Reported' '' '' '' ' ' '' ' ' '' ' ' '' ''

'PY1' 'DPH' 'Alameda Health System' 'Q-RU4' 'Unplanned Reoperation within the 30 Day Postoperative Period (QPP)' 'Not Reported' '' '' '' ' ' '' ' ' '' ' ' '' ''

'PY1' 'DPH' 'Alameda Health System' 'Q-RU5' 'Concurrent Use of Opioids and Benzodiazepines' 'Reported' 'N/A' '3' 'N/A' 'N/A' '3' 'N/A' '3' '6.10%%' '0' '1'

'PY1' 'DPH' 'Alameda Health System' 'Q-RU5' '? RATE #1' 'Reported' '0' '0' '0' '42' '0' '689' '0' '0.00%%' '0' '1'

'PY1' 'DPH' 'Alameda Health System' 'Q-RU5' '? RATE #2' 'Reported' '0' '0' '0' '67' '0' '985' '0' '0.00%%' '0' '1'

'PY1' 'DPH' 'Arrowhead Regional Medical Center' 'Q-PC1' 'Comprehensive Diabetes Care: A1C Control (<8%%) (CDC-H8)' 'Reported' '0' '0' '0' '840' '0' '1547' '0' '54.30%%' '0' '1'

'PY1' 'DPH' 'Arrowhead Regional Medical Center' 'Q-PC2' 'Comprehensive Diabetes Care: Eye Exam (CDC-E)' 'Reported' '0' '0' '0' '538' '0' '1547' '0' '34.80%%' '0' '1'

'PY1' 'DPH' 'Arrowhead Regional Medical Center' 'Q-PC3' 'Comprehensive Diabetes Care: Blood Pressure Control (CDC-BP)' 'Reported' '0' '0' '0' '571' '0' '1547' '0' '36.90%%' '0' '1'

'PY1' 'DPH' 'Arrowhead Regional Medical Center' 'Q-PC4' 'Asthma Medication Ratio (AMR)' 'Reported' '0' '0' '0' '0' '0' '0' '0' '0.00%%' '0' '1'

'PY1' 'DPH' 'Arrowhead Regional Medical Center' 'Q-PC5' 'Medication Reconciliation Post Discharge (MRP)' 'Reported' '0' '0' '0' '634' '0' '927' '0' '68.40%%' '0' '1'

'PY1' 'DPH' 'Arrowhead Regional Medical Center' 'Q-PC6' '7 Day Post-Discharge Follow-Up for High Risk Beneficiaries' 'Reported' '0' '0' '0' '242' '0' '459' '0' '52.70%%' '0' '1'

'PY1' 'DPH' 'Arrowhead Regional Medical Center' 'Q-PC7' 'Children and Adolescent Access to PCP (CAP)' 'Reported' 'N/A' '3' 'N/A' '' '' '' '' '' '' '1'

'PY1' 'DPH' 'Arrowhead Regional Medical Center' 'Q-PC7' '? 12-24 Months' 'Reported' '0' '0' '0' '0' '0' '' '1' '' '1' '1'

'PY1' 'DPH' 'Arrowhead Regional Medical Center' 'Q-PC7' '? 25 Months-6 Years' 'Reported' '0' '0' '0' '568' '0' '766' '0' '74.20%%' '0' '1'

'PY1' 'DPH' 'Arrowhead Regional Medical Center' 'Q-PC7' '? 7-11 Years' 'Reported' '0' '0' '0' '482' '0' '629' '0' '76.60%%' '0' '1'

'PY1' 'DPH' 'Arrowhead Regional Medical Center' 'Q-PC7' '? 12-19 Years' 'Reported' '0' '0' '0' '650' '0' '905' '0' '71.80%%' '0' '1'

'PY1' 'DPH' 'Arrowhead Regional Medical Center' 'Q-PC8' 'Childhood Immunization Status (CIS) Combination 3' 'Reported' '0' '0' '0' '81' '0' '169' '0' '47.90%%' '0' '1'

'PY1' 'DPH' 'Arrowhead Regional Medical Center' 'Q-PC9' 'Immunization for Adolescents (IMA) Combination 2' 'Reported' '0' '0' '0' '72' '0' '124' '0' '58.10%%' '0' '1'

'PY1' 'DPH' 'Arrowhead Regional Medical Center' 'Q-SC1' 'Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy' 'Reported' '0' '0' '0' '24' '0' '64' '0' '37.50%%' '0' '1'

'PY1' 'DPH' 'Arrowhead Regional Medical Center' 'Q-SC2' 'Coronary Artery Disease (CAD): Antiplatelet Therapy' 'Reported' '0' '0' '0' '61' '0' '209' '0' '29.20%%' '0' '1'

'PY1' 'DPH' 'Arrowhead Regional Medical Center' 'Q-SC3' 'Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%%)' 'Reported' '0' '0' '0' '52' '0' '209' '0' '24.90%%' '0' '1'

'PY1' 'DPH' 'Arrowhead Regional Medical Center' 'Q-SC4' 'Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%%)' 'Reported' '0' '0' '0' '51' '0' '209' '0' '24.40%%' '0' '1'

'PY1' 'DPH' 'Arrowhead Regional Medical Center' 'Q-SC5' 'Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction' 'Reported' '0' '0' '0' '77' '0' '201' '0' '38.30%%' '0' '1'

'PY1' 'DPH' 'Arrowhead Regional Medical Center' 'Q-SC6' 'Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction' 'Reported' '0' '0' '0' '82' '0' '201' '0' '40.80%%' '0' '1'

'PY1' 'DPH' 'Arrowhead Regional Medical Center' 'Q-IP1' 'Surgical Site Infection (SSI) (Reported as SIR)' 'Reported' '0' '0' '0' '' '1' '11.81' '0' '' '1' '1'

'PY1' 'DPH' 'Arrowhead Regional Medical Center' 'Q-IP2' 'Perioperative Care: Selection of Prophylactic Antibiotic - 1st OR 2nd Generation Cephalosporin' 'Reported' '0' '0' '0' '0' '0' '54' '0' '0.00%%' '0' '1'

'PY1' 'DPH' 'Arrowhead Regional Medical Center' 'Q-IP3' 'Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis' 'Reported' '0' '0' '0' '' '1' '53' '0' '' '1' '1'

'PY1' 'DPH' 'Arrowhead Regional Medical Center' 'Q-IP4' 'Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections' 'Reported' '0' '0' '0' '12' '0' '30' '0' '40.00%%' '0' '1'

'PY1' 'DPH' 'Arrowhead Regional Medical Center' 'Q-IP5' 'Appropriate Treatment of Methicillin-Sensitive Staphylococcus Aureus (MSSA) Bacteremia' 'Reported' '0' '0' '0' '0' '0' '' '1' '' '1' '1'

'PY1' 'DPH' 'Arrowhead Regional Medical Center' 'Q-IP6' 'Stroke: Discharged on Antithrombotic Therapy (TJC STK-2)' 'Reported' '0' '0' '0' '27' '0' '' '4' '' '4' '1'

'PY1' 'DPH' 'Arrowhead Regional Medical Center' 'Q-RU1' 'Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low Risk Surgery Patients (QPP)' 'Not Reported' '' '' '' ' ' '' ' ' '' ' ' '' ''

'PY1' 'DPH' 'Arrowhead Regional Medical Center' 'Q-RU2' 'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients 18 Years and Older' 'Not Reported' '' '' '' ' ' '' ' ' '' ' ' '' ''

'PY1' 'DPH' 'Arrowhead Regional Medical Center' 'Q-RU3' 'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 to 17 years old' 'Not Reported' '' '' '' ' ' '' ' ' '' ' ' '' ''

'PY1' 'DPH' 'Arrowhead Regional Medical Center' 'Q-RU4' 'Unplanned Reoperation within the 30 Day Postoperative Period (QPP)' 'Reported' '0' '0' '0' '' '1' '385' '0' '' '1' '1'

'PY1' 'DPH' 'Arrowhead Regional Medical Center' 'Q-RU5' 'Concurrent Use of Opioids and Benzodiazepines' 'Reported' 'N/A' '3' 'N/A' 'N/A' '3' 'N/A' '3' 'N/A' '3' '1'

'PY1' 'DPH' 'Arrowhead Regional Medical Center' 'Q-RU5' '? RATE #1' 'Reported' '0' '0' '0' '11' '0' '45' '0' '24.40%%' '0' '1'

'PY1' 'DPH' 'Arrowhead Regional Medical Center' 'Q-RU5' '? RATE #2' 'Reported' '0' '0' '0' '15' '0' '57' '0' '26.30%%' '0' '1'

'PY1' 'DPH' 'Contra Costa Regional Medical Center' 'Q-PC1' 'Comprehensive Diabetes Care: A1C Control (<8%%) (CDC-H8)' 'Reported' '0' '0' '0' '2435' '0' '4221' '0' '57.70%%' '0' '1'

'PY1' 'DPH' 'Contra Costa Regional Medical Center' 'Q-PC2' 'Comprehensive Diabetes Care: Eye Exam (CDC-E)' 'Reported' '0' '0' '0' '2350' '0' '4221' '0' '55.70%%' '0' '1'

'PY1' 'DPH' 'Contra Costa Regional Medical Center' 'Q-PC3' 'Comprehensive Diabetes Care: Blood Pressure Control (CDC-BP)' 'Reported' '0' '0' '0' '3196' '0' '4221' '0' '75.70%%' '0' '1'

'PY1' 'DPH' 'Contra Costa Regional Medical Center' 'Q-PC4' 'Asthma Medication Ratio (AMR)' 'Reported' '0' '0' '0' '534' '0' '1007' '0' '53.00%%' '0' '1'

'PY1' 'DPH' 'Contra Costa Regional Medical Center' 'Q-PC5' 'Medication Reconciliation Post Discharge (MRP)' 'Reported' '0' '0' '0' '2303' '0' '2316' '0' '99.40%%' '0' '1'

'PY1' 'DPH' 'Contra Costa Regional Medical Center' 'Q-PC6' '7 Day Post-Discharge Follow-Up for High Risk Beneficiaries' 'Reported' '0' '0' '0' '127' '0' '282' '0' '45.00%%' '0' '1'

'PY1' 'DPH' 'Contra Costa Regional Medical Center' 'Q-PC7' 'Children and Adolescent Access to PCP (CAP)' 'Reported' 'N/A' '3' 'N/A' '' '' '' '' '' '' '1'

'PY1' 'DPH' 'Contra Costa Regional Medical Center' 'Q-PC7' '? 12-24 Months' 'Reported' '0' '0' '0' '1140' '0' '1220' '0' '93.40%%' '0' '1'

'PY1' 'DPH' 'Contra Costa Regional Medical Center' 'Q-PC7' '? 25 Months-6 Years' 'Reported' '0' '0' '0' '5218' '0' '6274' '0' '83.20%%' '0' '1'

'PY1' 'DPH' 'Contra Costa Regional Medical Center' 'Q-PC7' '? 7-11 Years' 'Reported' '0' '0' '0' '4491' '0' '5258' '0' '85.40%%' '0' '1'

'PY1' 'DPH' 'Contra Costa Regional Medical Center' 'Q-PC7' '? 12-19 Years' 'Reported' '0' '0' '0' '5362' '0' '6435' '0' '83.30%%' '0' '1'

'PY1' 'DPH' 'Contra Costa Regional Medical Center' 'Q-PC8' 'Childhood Immunization Status (CIS) Combination 3' 'Reported' '0' '0' '0' '958' '0' '1163' '0' '82.40%%' '0' '1'

'PY1' 'DPH' 'Contra Costa Regional Medical Center' 'Q-PC9' 'Immunization for Adolescents (IMA) Combination 2' 'Reported' '0' '0' '0' '362' '0' '747' '0' '48.50%%' '0' '1'

'PY1' 'DPH' 'Contra Costa Regional Medical Center' 'Q-SC1' 'Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy' 'Reported' '0' '0' '0' '341' '0' '440' '0' '77.50%%' '0' '1'

'PY1' 'DPH' 'Contra Costa Regional Medical Center' 'Q-SC2' 'Coronary Artery Disease (CAD): Antiplatelet Therapy' 'Reported' '0' '0' '0' '1550' '0' '1700' '0' '91.20%%' '0' '1'

'PY1' 'DPH' 'Contra Costa Regional Medical Center' 'Q-SC3' 'Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%%)' 'Reported' '0' '0' '0' '694' '0' '911' '0' '76.20%%' '0' '1'

'PY1' 'DPH' 'Contra Costa Regional Medical Center' 'Q-SC4' 'Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%%)' 'Reported' '0' '0' '0' '295' '0' '335' '0' '88.10%%' '0' '1'

'PY1' 'DPH' 'Contra Costa Regional Medical Center' 'Q-SC5' 'Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction' 'Reported' '0' '0' '0' '325' '0' '400' '0' '81.30%%' '0' '1'

'PY1' 'DPH' 'Contra Costa Regional Medical Center' 'Q-SC6' 'Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction' 'Reported' '0' '0' '0' '398' '0' '421' '0' '94.50%%' '0' '1'

'PY1' 'DPH' 'Contra Costa Regional Medical Center' 'Q-IP1' 'Surgical Site Infection (SSI) (Reported as SIR)' 'Reported' '0' '0' '0' '' '1' '4.578' '0' '' '1' '1'

'PY1' 'DPH' 'Contra Costa Regional Medical Center' 'Q-IP2' 'Perioperative Care: Selection of Prophylactic Antibiotic - 1st OR 2nd Generation Cephalosporin' 'Reported' '0' '0' '0' '635' '0' '658' '0' '96.50%%' '0' '1'

'PY1' 'DPH' 'Contra Costa Regional Medical Center' 'Q-IP3' 'Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis' 'Reported' '0' '0' '0' '739' '0' '753' '0' '98.10%%' '0' '1'

'PY1' 'DPH' 'Contra Costa Regional Medical Center' 'Q-IP4' 'Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections' 'Reported' '0' '0' '0' '' '1' '195' '0' '' '1' '1'

'PY1' 'DPH' 'Contra Costa Regional Medical Center' 'Q-IP5' 'Appropriate Treatment of Methicillin-Sensitive Staphylococcus Aureus (MSSA) Bacteremia' 'Not Reported' '' '' '' ' ' '' ' ' '' ' ' '' ''

'PY1' 'DPH' 'Contra Costa Regional Medical Center' 'Q-IP6' 'Stroke: Discharged on Antithrombotic Therapy (TJC STK-2)' 'Not Reported' '' '' '' ' ' '' ' ' '' ' ' '' ''

'PY1' 'DPH' 'Contra Costa Regional Medical Center' 'Q-RU1' 'Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low Risk Surgery Patients (QPP)' 'Reported' '0' '0' '0' '' '1' '954' '0' '' '1' '1'

'PY1' 'DPH' 'Contra Costa Regional Medical Center' 'Q-RU2' 'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients 18 Years and Older' 'Not Reported' '' '' '' ' ' '' ' ' '' ' ' '' ''

'PY1' 'DPH' 'Contra Costa Regional Medical Center' 'Q-RU3' 'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 to 17 years old' 'Not Reported' '' '' '' ' ' '' ' ' '' ' ' '' ''

'PY1' 'DPH' 'Contra Costa Regional Medical Center' 'Q-RU4' 'Unplanned Reoperation within the 30 Day Postoperative Period (QPP)' 'Not Reported' '' '' '' '' '' '' '' '' '' ''

'PY1' 'DPH' 'Contra Costa Regional Medical Center' 'Q-RU5' 'Concurrent Use of Opioids and Benzodiazepines' 'Reported' 'N/A' '3' 'N/A' 'N/A' '3' 'N/A' '3' 'N/A' '3' '1'

'PY1' 'DPH' 'Contra Costa Regional Medical Center' 'Q-RU5' '? RATE #1' 'Reported' '0' '0' '0' '358' '0' '4950' '0' '7.20%%' '0' '1'

'PY1' 'DPH' 'Contra Costa Regional Medical Center' 'Q-RU5' '? RATE #2' 'Reported' '0' '0' '0' '474' '0' '4950' '0' '9.60%%' '0' '1'

'PY1' 'DPH' 'Kern Medical Center' 'Q-PC1' 'Comprehensive Diabetes Care: A1C Control (<8%%) (CDC-H8)' 'Reported' '0' '0' '0' '842' '0' '1532' '0' '55.00%%' '0' '1'

'PY1' 'DPH' 'Kern Medical Center' 'Q-PC2' 'Comprehensive Diabetes Care: Eye Exam (CDC-E)' 'Reported' '0' '0' '0' '659' '0' '1532' '0' '43.00%%' '0' '1'

'PY1' 'DPH' 'Kern Medical Center' 'Q-PC3' 'Comprehensive Diabetes Care: Blood Pressure Control (CDC-BP)' 'Reported' '0' '0' '0' '1068' '0' '1532' '0' '69.70%%' '0' '1'

'PY1' 'DPH' 'Kern Medical Center' 'Q-PC4' 'Asthma Medication Ratio (AMR)' 'Reported' '0' '0' '0' '' '1' '118' '0' '' '1' '1'

'PY1' 'DPH' 'Kern Medical Center' 'Q-PC5' 'Medication Reconciliation Post Discharge (MRP)' 'Reported' '0' '0' '0' '460' '0' '678' '0' '67.90%%' '0' '1'

'PY1' 'DPH' 'Kern Medical Center' 'Q-PC6' '7 Day Post-Discharge Follow-Up for High Risk Beneficiaries' 'Reported' '0' '0' '0' '24' '0' '93' '0' '25.80%%' '0' '1'

'PY1' 'DPH' 'Kern Medical Center' 'Q-PC7' 'Children and Adolescent Access to PCP (CAP)' 'Reported' 'N/A' '3' 'N/A' '' '' '' '' '' '' '1'

'PY1' 'DPH' 'Kern Medical Center' 'Q-PC7' '? 12-24 Months' 'Reported' '0' '0' '0' '501' '0' '687' '0' '72.90%%' '0' '1'

'PY1' 'DPH' 'Kern Medical Center' 'Q-PC7' '? 25 Months-6 Years' 'Reported' '0' '0' '0' '1840' '0' '3032' '0' '60.70%%' '0' '1'

'PY1' 'DPH' 'Kern Medical Center' 'Q-PC7' '? 7-11 Years' 'Reported' '0' '0' '0' '1916' '0' '3494' '0' '54.80%%' '0' '1'

'PY1' 'DPH' 'Kern Medical Center' 'Q-PC7' '? 12-19 Years' 'Reported' '0' '0' '0' '2378' '0' '4555' '0' '52.20%%' '0' '1'

'PY1' 'DPH' 'Kern Medical Center' 'Q-PC8' 'Childhood Immunization Status (CIS) Combination 3' 'Reported' '0' '0' '0' '100' '0' '408' '0' '24.50%%' '0' '1'

'PY1' 'DPH' 'Kern Medical Center' 'Q-PC9' 'Immunization for Adolescents (IMA) Combination 2' 'Reported' '0' '0' '0' '47' '0' '151' '0' '31.10%%' '0' '1'

'PY1' 'DPH' 'Kern Medical Center' 'Q-SC1' 'Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy' 'Reported' '0' '0' '0' '99' '0' '110' '0' '90.00%%' '0' '1'

'PY1' 'DPH' 'Kern Medical Center' 'Q-SC2' 'Coronary Artery Disease (CAD): Antiplatelet Therapy' 'Reported' '0' '0' '0' '472' '0' '513' '0' '92.00%%' '0' '1'

'PY1' 'DPH' 'Kern Medical Center' 'Q-SC3' 'Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%%)' 'Reported' '0' '0' '0' '354' '0' '399' '0' '88.70%%' '0' '1'

'PY1' 'DPH' 'Kern Medical Center' 'Q-SC4' 'Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%%)' 'Reported' '0' '0' '0' '140' '0' '156' '0' '89.70%%' '0' '1'

'PY1' 'DPH' 'Kern Medical Center' 'Q-SC5' 'Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction' 'Reported' '0' '0' '0' '104' '0' '109' '0' '95.40%%' '0' '1'

'PY1' 'DPH' 'Kern Medical Center' 'Q-SC6' 'Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction' 'Reported' '0' '0' '0' '97' '0' '101' '0' '96.00%%' '0' '1'

'PY1' 'DPH' 'Kern Medical Center' 'Q-IP1' 'Surgical Site Infection (SSI) (Reported as SIR)' 'Reported' '0' '0' '0' '15' '0' '8.41' '0' '1.7836' '0' '1'

'PY1' 'DPH' 'Kern Medical Center' 'Q-IP2' 'Perioperative Care: Selection of Prophylactic Antibiotic - 1st OR 2nd Generation Cephalosporin' 'Reported' '0' '0' '0' '1032' '0' '1032' '0' '100.00%%' '0' '1'

'PY1' 'DPH' 'Kern Medical Center' 'Q-IP3' 'Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis' 'Reported' '0' '0' '0' '958' '0' '958' '0' '100.00%%' '0' '1'

'PY1' 'DPH' 'Kern Medical Center' 'Q-IP4' 'Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections' 'Reported' '0' '0' '0' '457' '0' '475' '0' '96.20%%' '0' '1'

'PY1' 'DPH' 'Kern Medical Center' 'Q-IP5' 'Appropriate Treatment of Methicillin-Sensitive Staphylococcus Aureus (MSSA) Bacteremia' 'Not Reported' '' '' '' ' ' '' ' ' '' ' ' '' ''

'PY1' 'DPH' 'Kern Medical Center' 'Q-IP6' 'Stroke: Discharged on Antithrombotic Therapy (TJC STK-2)' 'Reported' '0' '0' '0' '31' '0' '32' '0' '96.90%%' '0' '1'

'PY1' 'DPH' 'Kern Medical Center' 'Q-RU1' 'Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low Risk Surgery Patients (QPP)' 'Reported' '0' '0' '0' '0' '0' '0' '0' '0.00%%' '0' '1'

'PY1' 'DPH' 'Kern Medical Center' 'Q-RU2' 'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients 18 Years and Older' 'Reported' '0' '0' '0' '0' '0' '0' '0' '100.00%%' '0' '1'

'PY1' 'DPH' 'Kern Medical Center' 'Q-RU3' 'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 to 17 years old' 'Not Reported' '' '' '' ' ' '' ' ' '' ' ' '' ''

'PY1' 'DPH' 'Kern Medical Center' 'Q-RU4' 'Unplanned Reoperation within the 30 Day Postoperative Period (QPP)' 'Reported' '0' '0' '0' '11' '0' '1029' '0' '1.10%%' '0' '1'

'PY1' 'DPH' 'Kern Medical Center' 'Q-RU5' 'Concurrent Use of Opioids and Benzodiazepines' 'Reported' 'N/A' '3' 'N/A' 'N/A' '3' 'N/A' '3' 'N/A' '3' '1'

'PY1' 'DPH' 'Kern Medical Center' 'Q-RU5' '? RATE #1' 'Reported' '0' '0' '0' '59' '0' '482' '0' '12.20%%' '0' '1'

'PY1' 'DPH' 'Kern Medical Center' 'Q-RU5' '? RATE #2' 'Reported' '0' '0' '0' '56' '0' '503' '0' '11.10%%' '0' '1'

'PY1' 'DPH' 'Los Angeles County Health System' 'Q-PC1' 'Comprehensive Diabetes Care: A1C Control (<8%%) (CDC-H8)' 'Reported' '0' '0' '0' '8169' '0' '15547' '0' '52.50%%' '0' '1'

'PY1' 'DPH' 'Los Angeles County Health System' 'Q-PC2' 'Comprehensive Diabetes Care: Eye Exam (CDC-E)' 'Reported' '0' '0' '0' '271' '0' '377' '0' '71.90%%' '0' '1'

'PY1' 'DPH' 'Los Angeles County Health System' 'Q-PC3' 'Comprehensive Diabetes Care: Blood Pressure Control (CDC-BP)' 'Reported' '0' '0' '0' '10278' '0' '15547' '0' '66.10%%' '0' '1'

'PY1' 'DPH' 'Los Angeles County Health System' 'Q-PC4' 'Asthma Medication Ratio (AMR)' 'Reported' '0' '0' '0' '450' '0' '945' '0' '47.60%%' '0' '1'

'PY1' 'DPH' 'Los Angeles County Health System' 'Q-PC5' 'Medication Reconciliation Post Discharge (MRP)' 'Reported' '0' '0' '0' '3941' '0' '8633' '0' '45.70%%' '0' '1'

'PY1' 'DPH' 'Los Angeles County Health System' 'Q-PC6' '7 Day Post-Discharge Follow-Up for High Risk Beneficiaries' 'Not Reported' '' '' '' '' '' ' ' '' ' ' '' ''

'PY1' 'DPH' 'Los Angeles County Health System' 'Q-PC7' 'Children and Adolescent Access to PCP (CAP)' 'Reported' 'N/A' '3' 'N/A' '' '' '' '' '' '' '1'

'PY1' 'DPH' 'Los Angeles County Health System' 'Q-PC7' '? 12-24 Months' 'Reported' '0' '0' '0' '1279' '0' '1490' '0' '85.80%%' '0' '1'

'PY1' 'DPH' 'Los Angeles County Health System' 'Q-PC7' '? 25 Months-6 Years' 'Reported' '0' '0' '0' '5977' '0' '8822' '0' '67.80%%' '0' '1'

'PY1' 'DPH' 'Los Angeles County Health System' 'Q-PC7' '? 7-11 Years' 'Reported' '0' '0' '0' '5108' '0' '7441' '0' '68.70%%' '0' '1'

'PY1' 'DPH' 'Los Angeles County Health System' 'Q-PC7' '? 12-19 Years' 'Reported' '0' '0' '0' '7373' '0' '11345' '0' '65.00%%' '0' '1'

'PY1' 'DPH' 'Los Angeles County Health System' 'Q-PC8' 'Childhood Immunization Status (CIS) Combination 3' 'Reported' '0' '0' '0' '279' '0' '323' '0' '86.40%%' '0' '1'

'PY1' 'DPH' 'Los Angeles County Health System' 'Q-PC9' 'Immunization for Adolescents (IMA) Combination 2' 'Not Reported' '' '' '' '' '' '' '' '' '' ''

'PY1' 'DPH' 'Los Angeles County Health System' 'Q-SC1' 'Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy' 'Reported' '0' '0' '0' '678' '0' '860' '0' '78.80%%' '0' '1'

'PY1' 'DPH' 'Los Angeles County Health System' 'Q-SC2' 'Coronary Artery Disease (CAD): Antiplatelet Therapy' 'Reported' '0' '0' '0' '2991' '0' '3209' '0' '93.20%%' '0' '1'

'PY1' 'DPH' 'Los Angeles County Health System' 'Q-SC3' 'Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%%)' 'Reported' '0' '0' '0' '1560' '0' '1808' '0' '86.30%%' '0' '1'

'PY1' 'DPH' 'Los Angeles County Health System' 'Q-SC4' 'Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%%)' 'Reported' '0' '0' '0' '1037' '0' '1216' '0' '85.30%%' '0' '1'

'PY1' 'DPH' 'Los Angeles County Health System' 'Q-SC5' 'Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction' 'Reported' '0' '0' '0' '475' '0' '603' '0' '78.80%%' '0' '1'

'PY1' 'DPH' 'Los Angeles County Health System' 'Q-SC6' 'Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction' 'Reported' '0' '0' '0' '546' '0' '609' '0' '89.70%%' '0' '1'

'PY1' 'DPH' 'Los Angeles County Health System' 'Q-IP1' 'Surgical Site Infection (SSI) (Reported as SIR)' 'Reported' '0' '0' '0' '11' '0' '22.472' '0' '0.4895' '0' '1'

'PY1' 'DPH' 'Los Angeles County Health System' 'Q-IP2' 'Perioperative Care: Selection of Prophylactic Antibiotic - 1st OR 2nd Generation Cephalosporin' 'Reported' '0' '0' '0' '340' '0' '370' '0' '91.90%%' '0' '1'

'PY1' 'DPH' 'Los Angeles County Health System' 'Q-IP3' 'Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis' 'Reported' '0' '0' '0' '299' '0' '370' '0' '80.80%%' '0' '1'

'PY1' 'DPH' 'Los Angeles County Health System' 'Q-IP4' 'Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections' 'Reported' '0' '0' '0' '214' '0' '370' '0' '57.80%%' '0' '1'

'PY1' 'DPH' 'Los Angeles County Health System' 'Q-IP5' 'Appropriate Treatment of Methicillin-Sensitive Staphylococcus Aureus (MSSA) Bacteremia' 'Reported' '0' '0' '0' '101' '0' '103' '0' '98.10%%' '0' '1'

'PY1' 'DPH' 'Los Angeles County Health System' 'Q-IP6' 'Stroke: Discharged on Antithrombotic Therapy (TJC STK-2)' 'Reported' '0' '0' '0' '204' '0' '205' '0' '99.50%%' '0' '1'

'PY1' 'DPH' 'Los Angeles County Health System' 'Q-RU1' 'Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low Risk Surgery Patients (QPP)' 'Reported' '0' '0' '0' '' '1' '377' '0' '' '1' '1'

'PY1' 'DPH' 'Los Angeles County Health System' 'Q-RU2' 'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients 18 Years and Older' 'Not Reported' '' '' '' '' '' '' '' '' '' ''

'PY1' 'DPH' 'Los Angeles County Health System' 'Q-RU3' 'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 to 17 years old' 'Not Reported' '' '' '' '' '' '' '' '' '' ''

'PY1' 'DPH' 'Los Angeles County Health System' 'Q-RU4' 'Unplanned Reoperation within the 30 Day Postoperative Period (QPP)' 'Not Reported' '' '' '' '' '' '' '' '' '' ''

'PY1' 'DPH' 'Los Angeles County Health System' 'Q-RU5' 'Concurrent Use of Opioids and Benzodiazepines' 'Not Reported' '' '' '' '' '' '' '' '' '' ''

'PY1' 'DPH' 'Natividad Medical Center' 'Q-PC1' 'Comprehensive Diabetes Care: A1C Control (<8%%) (CDC-H8)' 'Reported' '0' '0' '0' '647' '0' '1259' '0' '51.40%%' '0' '1'

'PY1' 'DPH' 'Natividad Medical Center' 'Q-PC2' 'Comprehensive Diabetes Care: Eye Exam (CDC-E)' 'Reported' '0' '0' '0' '784' '0' '1259' '0' '62.30%%' '0' '1'

'PY1' 'DPH' 'Natividad Medical Center' 'Q-PC3' 'Comprehensive Diabetes Care: Blood Pressure Control (CDC-BP)' 'Reported' '0' '0' '0' '926' '0' '1259' '0' '73.60%%' '0' '1'

'PY1' 'DPH' 'Natividad Medical Center' 'Q-PC4' 'Asthma Medication Ratio (AMR)' 'Reported' '0' '0' '0' '264' '0' '406' '0' '65.00%%' '0' '1'

'PY1' 'DPH' 'Natividad Medical Center' 'Q-PC5' 'Medication Reconciliation Post Discharge (MRP)' 'Reported' '0' '0' '0' '419' '0' '729' '0' '57.50%%' '0' '1'

'PY1' 'DPH' 'Natividad Medical Center' 'Q-PC6' '7 Day Post-Discharge Follow-Up for High Risk Beneficiaries' 'Reported' '0' '0' '0' '22' '0' '45' '0' '48.90%%' '0' '1'

'PY1' 'DPH' 'Natividad Medical Center' 'Q-PC7' 'Children and Adolescent Access to PCP (CAP)' 'Reported' 'N/A' '3' 'N/A' '' '' '' '' '' '' '1'

'PY1' 'DPH' 'Natividad Medical Center' 'Q-PC7' '? 12-24 Months' 'Reported' '0' '0' '0' '1421' '0' '1497' '0' '94.90%%' '0' '1'

'PY1' 'DPH' 'Natividad Medical Center' 'Q-PC7' '? 25 Months-6 Years' 'Reported' '0' '0' '0' '6462' '0' '7113' '0' '90.90%%' '0' '1'

'PY1' 'DPH' 'Natividad Medical Center' 'Q-PC7' '? 7-11 Years' 'Reported' '0' '0' '0' '6577' '0' '7365' '0' '89.30%%' '0' '1'

'PY1' 'DPH' 'Natividad Medical Center' 'Q-PC7' '? 12-19 Years' 'Reported' '0' '0' '0' '6787' '0' '8060' '0' '84.20%%' '0' '1'

'PY1' 'DPH' 'Natividad Medical Center' 'Q-PC8' 'Childhood Immunization Status (CIS) Combination 3' 'Reported' '0' '0' '0' '869' '0' '989' '0' '87.90%%' '0' '1'

'PY1' 'DPH' 'Natividad Medical Center' 'Q-PC9' 'Immunization for Adolescents (IMA) Combination 2' 'Reported' '0' '0' '0' '561' '0' '770' '0' '72.90%%' '0' '1'

'PY1' 'DPH' 'Natividad Medical Center' 'Q-SC1' 'Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy' 'Reported' '0' '0' '0' '109' '0' '128' '0' '85.20%%' '0' '1'

'PY1' 'DPH' 'Natividad Medical Center' 'Q-SC2' 'Coronary Artery Disease (CAD): Antiplatelet Therapy' 'Reported' '0' '0' '0' '238' '0' '297' '0' '80.10%%' '0' '1'

'PY1' 'DPH' 'Natividad Medical Center' 'Q-SC3' 'Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%%)' 'Reported' '0' '0' '0' '133' '0' '161' '0' '82.60%%' '0' '1'

'PY1' 'DPH' 'Natividad Medical Center' 'Q-SC4' 'Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%%)' 'Reported' '0' '0' '0' '65' '0' '79' '0' '82.30%%' '0' '1'

'PY1' 'DPH' 'Natividad Medical Center' 'Q-SC5' 'Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction' 'Reported' '0' '0' '0' '28' '0' '35' '0' '80.00%%' '0' '1'

'PY1' 'DPH' 'Natividad Medical Center' 'Q-SC6' 'Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction' 'Reported' '0' '0' '0' '24' '0' '35' '0' '68.60%%' '0' '1'

'PY1' 'DPH' 'Natividad Medical Center' 'Q-IP1' 'Surgical Site Infection (SSI) (Reported as SIR)' 'Reported' '0' '0' '0' '' '1' '6.737' '0' '' '1' '1'

'PY1' 'DPH' 'Natividad Medical Center' 'Q-IP2' 'Perioperative Care: Selection of Prophylactic Antibiotic - 1st OR 2nd Generation Cephalosporin' 'Reported' '0' '0' '0' '338' '0' '794' '0' '42.60%%' '0' '1'

'PY1' 'DPH' 'Natividad Medical Center' 'Q-IP3' 'Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis' 'Reported' '0' '0' '0' '491' '0' '766' '0' '64.10%%' '0' '1'

'PY1' 'DPH' 'Natividad Medical Center' 'Q-IP4' 'Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections' 'Reported' '0' '0' '0' '376' '0' '467' '0' '80.50%%' '0' '1'

'PY1' 'DPH' 'Natividad Medical Center' 'Q-IP5' 'Appropriate Treatment of Methicillin-Sensitive Staphylococcus Aureus (MSSA) Bacteremia' 'Not Reported' '' '' '' ' ' '' ' ' '' ' ' '' ''

'PY1' 'DPH' 'Natividad Medical Center' 'Q-IP6' 'Stroke: Discharged on Antithrombotic Therapy (TJC STK-2)' 'Not Reported' '' '' '' ' ' '' ' ' '' ' ' '' ''

'PY1' 'DPH' 'Natividad Medical Center' 'Q-RU1' 'Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low Risk Surgery Patients (QPP)' 'Reported' '0' '0' '0' '' '1' '78' '0' '' '1' '1'

'PY1' 'DPH' 'Natividad Medical Center' 'Q-RU2' 'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients 18 Years and Older' 'Not Reported' '' '' '' ' ' '' ' ' '' ' ' '' ''

'PY1' 'DPH' 'Natividad Medical Center' 'Q-RU3' 'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 to 17 years old' 'Not Reported' '' '' '' ' ' '' ' ' '' ' ' '' ''

'PY1' 'DPH' 'Natividad Medical Center' 'Q-RU4' 'Unplanned Reoperation within the 30 Day Postoperative Period (QPP)' 'No Data Entered' '' '' '' '' '' '' '' '' '' ''

'PY1' 'DPH' 'Natividad Medical Center' 'Q-RU5' 'Concurrent Use of Opioids and Benzodiazepines' 'Reported' 'N/A' '3' 'N/A' 'N/A' '3' 'N/A' '3' 'N/A' '3' '1'

'PY1' 'DPH' 'Natividad Medical Center' 'Q-RU5' '? RATE #1' 'Reported' '0' '0' '0' '13' '0' '185' '0' '7.00%%' '0' '1'

'PY1' 'DPH' 'Natividad Medical Center' 'Q-RU5' '? RATE #2' 'Reported' '0' '0' '0' '50' '0' '548' '0' '9.10%%' '0' '1'

'PY1' 'DPH' 'Riverside University Health System' 'Q-PC1' 'Comprehensive Diabetes Care: A1C Control (<8%%) (CDC-H8)' 'Reported' '0' '0' '0' '601' '0' '1157' '0' '51.90%%' '0' '1'

'PY1' 'DPH' 'Riverside University Health System' 'Q-PC2' 'Comprehensive Diabetes Care: Eye Exam (CDC-E)' 'Reported' '0' '0' '0' '132' '0' '1157' '0' '11.40%%' '0' '1'

'PY1' 'DPH' 'Riverside University Health System' 'Q-PC3' 'Comprehensive Diabetes Care: Blood Pressure Control (CDC-BP)' 'Reported' '0' '0' '0' '692' '0' '1157' '0' '59.80%%' '0' '1'

'PY1' 'DPH' 'Riverside University Health System' 'Q-PC4' 'Asthma Medication Ratio (AMR)' 'Not Reported' '' '' '' ' ' '' ' ' '' ' ' '' ''

'PY1' 'DPH' 'Riverside University Health System' 'Q-PC5' 'Medication Reconciliation Post Discharge (MRP)' 'Reported' '0' '0' '0' '511' '0' '782' '0' '65.40%%' '0' '1'

'PY1' 'DPH' 'Riverside University Health System' 'Q-PC6' '7 Day Post-Discharge Follow-Up for High Risk Beneficiaries' 'Reported' '0' '0' '0' '77' '0' '239' '0' '32.20%%' '0' '1'

'PY1' 'DPH' 'Riverside University Health System' 'Q-PC7' 'Children and Adolescent Access to PCP (CAP)' 'Not Reported' '' '' '' ' ' '' ' ' '' ' ' '' ''

'PY1' 'DPH' 'Riverside University Health System' 'Q-PC8' 'Childhood Immunization Status (CIS) Combination 3' 'Not Reported' '' '' '' ' ' '' ' ' '' ' ' '' ''

'PY1' 'DPH' 'Riverside University Health System' 'Q-PC9' 'Immunization for Adolescents (IMA) Combination 2' 'Reported' '0' '0' '0' '34' '0' '101' '0' '33.70%%' '0' '1'

'PY1' 'DPH' 'Riverside University Health System' 'Q-SC1' 'Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy' 'Reported' '0' '0' '0' '77' '0' '142' '0' '54.20%%' '0' '1'

'PY1' 'DPH' 'Riverside University Health System' 'Q-SC2' 'Coronary Artery Disease (CAD): Antiplatelet Therapy' 'Reported' '0' '0' '0' '727' '0' '849' '0' '85.60%%' '0' '1'

'PY1' 'DPH' 'Riverside University Health System' 'Q-SC3' 'Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%%)' 'Reported' '0' '0' '0' '386' '0' '445' '0' '86.70%%' '0' '1'

'PY1' 'DPH' 'Riverside University Health System' 'Q-SC4' 'Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%%)' 'Reported' '0' '0' '0' '227' '0' '342' '0' '66.40%%' '0' '1'

'PY1' 'DPH' 'Riverside University Health System' 'Q-SC5' 'Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction' 'Reported' '0' '0' '0' '315' '0' '374' '0' '84.20%%' '0' '1'

'PY1' 'DPH' 'Riverside University Health System' 'Q-SC6' 'Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction' 'Reported' '0' '0' '0' '315' '0' '389' '0' '81.00%%' '0' '1'

'PY1' 'DPH' 'Riverside University Health System' 'Q-IP1' 'Surgical Site Infection (SSI) (Reported as SIR)' 'Reported' '0' '0' '0' '12' '0' '9.855' '0' '1.2177' '0' '1'

'PY1' 'DPH' 'Riverside University Health System' 'Q-IP2' 'Perioperative Care: Selection of Prophylactic Antibiotic - 1st OR 2nd Generation Cephalosporin' 'Reported' '0' '0' '0' '326' '0' '433' '0' '75.30%%' '0' '1'

'PY1' 'DPH' 'Riverside University Health System' 'Q-IP3' 'Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis' 'Reported' '0' '0' '0' '43' '0' '418' '0' '10.30%%' '0' '1'

'PY1' 'DPH' 'Riverside University Health System' 'Q-IP4' 'Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections' 'Reported' '0' '0' '0' '238' '0' '773' '0' '30.80%%' '0' '1'

'PY1' 'DPH' 'Riverside University Health System' 'Q-IP5' 'Appropriate Treatment of Methicillin-Sensitive Staphylococcus Aureus (MSSA) Bacteremia' 'Not Reported' '' '' '' ' ' '' ' ' '' ' ' '' ''

'PY1' 'DPH' 'Riverside University Health System' 'Q-IP6' 'Stroke: Discharged on Antithrombotic Therapy (TJC STK-2)' 'Not Reported' '' '' '' ' ' '' ' ' '' ' ' '' ''

'PY1' 'DPH' 'Riverside University Health System' 'Q-RU1' 'Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low Risk Surgery Patients (QPP)' 'Reported' '0' '0' '0' '0' '0' '68' '0' '0.00%%' '0' '1'

'PY1' 'DPH' 'Riverside University Health System' 'Q-RU2' 'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients 18 Years and Older' 'Reported' '0' '0' '0' '31' '0' '39' '0' '79.50%%' '0' '1'

'PY1' 'DPH' 'Riverside University Health System' 'Q-RU3' 'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 to 17 years old' 'Not Reported' '' '' '' ' ' '' ' ' '' ' ' '' ''

'PY1' 'DPH' 'Riverside University Health System' 'Q-RU4' 'Unplanned Reoperation within the 30 Day Postoperative Period (QPP)' 'No Data Entered' '' '' '' '' '' '' '' '' '' ''

'PY1' 'DPH' 'Riverside University Health System' 'Q-RU5' 'Concurrent Use of Opioids and Benzodiazepines' 'Reported' 'N/A' '3' 'N/A' 'N/A' '3' 'N/A' '3' 'N/A' '3' '1'

'PY1' 'DPH' 'Riverside University Health System' 'Q-RU5' '? RATE #1' 'Reported' '0' '0' '0' '24' '0' '652' '0' '3.70%%' '0' '1'

'PY1' 'DPH' 'Riverside University Health System' 'Q-RU5' '? RATE #2' 'Reported' '0' '0' '0' '38' '0' '844' '0' '4.50%%' '0' '1'

'PY1' 'DPH' 'San Francisco General Hospital' 'Q-PC1' 'Comprehensive Diabetes Care: A1C Control (<8%%) (CDC-H8)' 'Reported' '0' '0' '0' '2060' '0' '3329' '0' '61.90%%' '0' '1'

'PY1' 'DPH' 'San Francisco General Hospital' 'Q-PC2' 'Comprehensive Diabetes Care: Eye Exam (CDC-E)' 'Reported' '0' '0' '0' '2205' '0' '3329' '0' '66.20%%' '0' '1'

'PY1' 'DPH' 'San Francisco General Hospital' 'Q-PC3' 'Comprehensive Diabetes Care: Blood Pressure Control (CDC-BP)' 'Reported' '0' '0' '0' '2517' '0' '3329' '0' '75.60%%' '0' '1'

'PY1' 'DPH' 'San Francisco General Hospital' 'Q-PC4' 'Asthma Medication Ratio (AMR)' 'Not Reported' '' '' '' ' ' '' ' ' '' ' ' '' ''

'PY1' 'DPH' 'San Francisco General Hospital' 'Q-PC5' 'Medication Reconciliation Post Discharge (MRP)' 'Reported' '0' '0' '0' '1551' '0' '2762' '0' '56.20%%' '0' '1'

'PY1' 'DPH' 'San Francisco General Hospital' 'Q-PC6' '7 Day Post-Discharge Follow-Up for High Risk Beneficiaries' 'Reported' '0' '0' '0' '235' '0' '476' '0' '49.40%%' '0' '1'

'PY1' 'DPH' 'San Francisco General Hospital' 'Q-PC7' 'Children and Adolescent Access to PCP (CAP)' 'Reported' 'N/A' '3' 'N/A' '' '' '' '' '' '' '1'

'PY1' 'DPH' 'San Francisco General Hospital' 'Q-PC7' '? 12-24 Months' 'Reported' '0' '0' '0' '344' '0' '355' '0' '96.90%%' '0' '1'

'PY1' 'DPH' 'San Francisco General Hospital' 'Q-PC7' '? 25 Months-6 Years' 'Reported' '0' '0' '0' '1949' '0' '2187' '0' '89.10%%' '0' '1'

'PY1' 'DPH' 'San Francisco General Hospital' 'Q-PC7' '? 7-11 Years' 'Reported' '0' '0' '0' '1518' '0' '1693' '0' '89.70%%' '0' '1'

'PY1' 'DPH' 'San Francisco General Hospital' 'Q-PC7' '? 12-19 Years' 'Reported' '0' '0' '0' '1643' '0' '1858' '0' '88.40%%' '0' '1'

'PY1' 'DPH' 'San Francisco General Hospital' 'Q-PC8' 'Childhood Immunization Status (CIS) Combination 3' 'Reported' '0' '0' '0' '404' '0' '448' '0' '90.20%%' '0' '1'

'PY1' 'DPH' 'San Francisco General Hospital' 'Q-PC9' 'Immunization for Adolescents (IMA) Combination 2' 'Reported' '0' '0' '0' '187' '0' '286' '0' '65.40%%' '0' '1'

'PY1' 'DPH' 'San Francisco General Hospital' 'Q-SC1' 'Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy' 'Reported' '0' '0' '0' '162' '0' '206' '0' '78.60%%' '0' '1'

'PY1' 'DPH' 'San Francisco General Hospital' 'Q-SC2' 'Coronary Artery Disease (CAD): Antiplatelet Therapy' 'Reported' '0' '0' '0' '809' '0' '862' '0' '93.90%%' '0' '1'

'PY1' 'DPH' 'San Francisco General Hospital' 'Q-SC3' 'Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%%)' 'Reported' '0' '0' '0' '446' '0' '516' '0' '86.40%%' '0' '1'

'PY1' 'DPH' 'San Francisco General Hospital' 'Q-SC4' 'Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%%)' 'Reported' '0' '0' '0' '198' '0' '206' '0' '96.10%%' '0' '1'

'PY1' 'DPH' 'San Francisco General Hospital' 'Q-SC5' 'Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction' 'Reported' '0' '0' '0' '340' '0' '396' '0' '85.90%%' '0' '1'

'PY1' 'DPH' 'San Francisco General Hospital' 'Q-SC6' 'Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction' 'Reported' '0' '0' '0' '378' '0' '401' '0' '94.30%%' '0' '1'

'PY1' 'DPH' 'San Francisco General Hospital' 'Q-IP1' 'Surgical Site Infection (SSI) (Reported as SIR)' 'Not Reported' '' '' '' ' ' '' ' ' '' ' ' '' ''

'PY1' 'DPH' 'San Francisco General Hospital' 'Q-IP2' 'Perioperative Care: Selection of Prophylactic Antibiotic - 1st OR 2nd Generation Cephalosporin' 'Reported' '0' '0' '0' '367' '0' '385' '0' '95.30%%' '0' '1'

'PY1' 'DPH' 'San Francisco General Hospital' 'Q-IP3' 'Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis' 'Reported' '0' '0' '0' '361' '0' '373' '0' '96.80%%' '0' '1'

'PY1' 'DPH' 'San Francisco General Hospital' 'Q-IP4' 'Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections' 'Reported' '0' '0' '0' '0' '0' '569' '0' '0.00%%' '0' '1'

'PY1' 'DPH' 'San Francisco General Hospital' 'Q-IP5' 'Appropriate Treatment of Methicillin-Sensitive Staphylococcus Aureus (MSSA) Bacteremia' 'Reported' '0' '0' '0' '31' '0' '31' '0' '100.00%%' '0' '1'

'PY1' 'DPH' 'San Francisco General Hospital' 'Q-IP6' 'Stroke: Discharged on Antithrombotic Therapy (TJC STK-2)' 'Reported' '0' '0' '0' '90' '0' '90' '0' '100.00%%' '0' '1'

'PY1' 'DPH' 'San Francisco General Hospital' 'Q-RU1' 'Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low Risk Surgery Patients (QPP)' 'Reported' '0' '0' '0' '' '1' '155' '0' '' '1' '1'

'PY1' 'DPH' 'San Francisco General Hospital' 'Q-RU2' 'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients 18 Years and Older' 'Not Reported' '' '' '' '' '' '' '' '' '' ''

'PY1' 'DPH' 'San Francisco General Hospital' 'Q-RU3' 'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 to 17 years old' 'Not Reported' '' '' '' '' '' '' '' '' '' ''

'PY1' 'DPH' 'San Francisco General Hospital' 'Q-RU4' 'Unplanned Reoperation within the 30 Day Postoperative Period (QPP)' 'Not Reported' '' '' '' '' '' '' '' '' '' ''

'PY1' 'DPH' 'San Francisco General Hospital' 'Q-RU5' 'Concurrent Use of Opioids and Benzodiazepines' 'Not Reported' '' '' '' '' '' '' '' '' '' ''

'PY1' 'DPH' 'San Joaquin General Hospital' 'Q-PC1' 'Comprehensive Diabetes Care: A1C Control (<8%%) (CDC-H8)' 'Reported' '0' '0' '0' '274' '0' '548' '0' '50.00%%' '0' '1'

'PY1' 'DPH' 'San Joaquin General Hospital' 'Q-PC2' 'Comprehensive Diabetes Care: Eye Exam (CDC-E)' 'Reported' '0' '0' '0' '259' '0' '548' '0' '47.30%%' '0' '1'

'PY1' 'DPH' 'San Joaquin General Hospital' 'Q-PC3' 'Comprehensive Diabetes Care: Blood Pressure Control (CDC-BP)' 'Reported' '0' '0' '0' '396' '0' '548' '0' '72.30%%' '0' '1'

'PY1' 'DPH' 'San Joaquin General Hospital' 'Q-PC4' 'Asthma Medication Ratio (AMR)' 'Reported' '0' '0' '0' '36' '0' '50' '0' '72.00%%' '0' '1'

'PY1' 'DPH' 'San Joaquin General Hospital' 'Q-PC5' 'Medication Reconciliation Post Discharge (MRP)' 'Reported' '0' '0' '0' '104' '0' '235' '0' '44.30%%' '0' '1'

'PY1' 'DPH' 'San Joaquin General Hospital' 'Q-PC6' '7 Day Post-Discharge Follow-Up for High Risk Beneficiaries' 'Reported' '0' '0' '0' '125' '0' '228' '0' '54.80%%' '0' '1'

'PY1' 'DPH' 'San Joaquin General Hospital' 'Q-PC7' 'Children and Adolescent Access to PCP (CAP)' 'Reported' 'N/A' '3' 'N/A' '' '' '' '' '' '' '1'

'PY1' 'DPH' 'San Joaquin General Hospital' 'Q-PC7' '? 12-24 Months' 'Reported' '0' '0' '0' '381' '0' '413' '0' '92.30%%' '0' '1'

'PY1' 'DPH' 'San Joaquin General Hospital' 'Q-PC7' '? 25 Months-6 Years' 'Reported' '0' '0' '0' '2025' '0' '2686' '0' '75.40%%' '0' '1'

'PY1' 'DPH' 'San Joaquin General Hospital' 'Q-PC7' '? 7-11 Years' 'Reported' '0' '0' '0' '2081' '0' '2924' '0' '71.20%%' '0' '1'

'PY1' 'DPH' 'San Joaquin General Hospital' 'Q-PC7' '? 12-19 Years' 'Reported' '0' '0' '0' '2844' '0' '4202' '0' '67.70%%' '0' '1'

'PY1' 'DPH' 'San Joaquin General Hospital' 'Q-PC8' 'Childhood Immunization Status (CIS) Combination 3' 'Reported' '0' '0' '0' '134' '0' '184' '0' '72.80%%' '0' '1'

'PY1' 'DPH' 'San Joaquin General Hospital' 'Q-PC9' 'Immunization for Adolescents (IMA) Combination 2' 'Reported' '0' '0' '0' '69' '0' '132' '0' '52.30%%' '0' '1'

'PY1' 'DPH' 'San Joaquin General Hospital' 'Q-SC1' 'Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy' 'Reported' '0' '0' '0' '66' '0' '73' '0' '90.40%%' '0' '1'

'PY1' 'DPH' 'San Joaquin General Hospital' 'Q-SC2' 'Coronary Artery Disease (CAD): Antiplatelet Therapy' 'Reported' '0' '0' '0' '134' '0' '161' '0' '83.20%%' '0' '1'

'PY1' 'DPH' 'San Joaquin General Hospital' 'Q-SC3' 'Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%%)' 'Reported' '0' '0' '0' '105' '0' '121' '0' '86.80%%' '0' '1'

'PY1' 'DPH' 'San Joaquin General Hospital' 'Q-SC4' 'Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%%)' 'Reported' '0' '0' '0' '87' '0' '104' '0' '83.70%%' '0' '1'

'PY1' 'DPH' 'San Joaquin General Hospital' 'Q-SC5' 'Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction' 'Reported' '0' '0' '0' '61' '0' '80' '0' '76.30%%' '0' '1'

'PY1' 'DPH' 'San Joaquin General Hospital' 'Q-SC6' 'Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction' 'Reported' '0' '0' '0' '61' '0' '80' '0' '76.30%%' '0' '1'

'PY1' 'DPH' 'San Joaquin General Hospital' 'Q-IP1' 'Surgical Site Infection (SSI) (Reported as SIR)' 'Not Reported' '' '' '' ' ' '' ' ' '' ' ' '' ''

'PY1' 'DPH' 'San Joaquin General Hospital' 'Q-IP2' 'Perioperative Care: Selection of Prophylactic Antibiotic - 1st OR 2nd Generation Cephalosporin' 'Reported' '0' '0' '0' '63' '0' '88' '0' '71.60%%' '0' '1'

'PY1' 'DPH' 'San Joaquin General Hospital' 'Q-IP3' 'Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis' 'Reported' '0' '0' '0' '82' '0' '98' '0' '83.70%%' '0' '1'

'PY1' 'DPH' 'San Joaquin General Hospital' 'Q-IP4' 'Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections' 'Reported' '0' '0' '0' '45' '0' '48' '0' '93.80%%' '0' '1'

'PY1' 'DPH' 'San Joaquin General Hospital' 'Q-IP5' 'Appropriate Treatment of Methicillin-Sensitive Staphylococcus Aureus (MSSA) Bacteremia' 'Reported' '0' '0' '0' '12' '0' '' '4' '' '4' '1'

'PY1' 'DPH' 'San Joaquin General Hospital' 'Q-IP6' 'Stroke: Discharged on Antithrombotic Therapy (TJC STK-2)' 'Reported' '0' '0' '0' '68' '0' '86' '0' '79.10%%' '0' '1'

'PY1' 'DPH' 'San Joaquin General Hospital' 'Q-RU1' 'Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low Risk Surgery Patients (QPP)' 'Not Reported' '' '' '' '' '' '' '' '' '' ''

'PY1' 'DPH' 'San Joaquin General Hospital' 'Q-RU2' 'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients 18 Years and Older' 'Not Reported' '' '' '' '' '' '' '' '' '' ''

'PY1' 'DPH' 'San Joaquin General Hospital' 'Q-RU3' 'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 to 17 years old' 'Not Reported' '' '' '' '' '' '' '' '' '' ''

'PY1' 'DPH' 'San Joaquin General Hospital' 'Q-RU4' 'Unplanned Reoperation within the 30 Day Postoperative Period (QPP)' 'Not Reported' '' '' '' '' '' '' '' '' '' ''

'PY1' 'DPH' 'San Joaquin General Hospital' 'Q-RU5' 'Concurrent Use of Opioids and Benzodiazepines' 'Not Reported' '' '' '' '' '' '' '' '' '' ''

'PY1' 'DPH' 'Santa Clara Valley Medical Center' 'Q-PC1' 'Comprehensive Diabetes Care: A1C Control (<8%%) (CDC-H8)' 'Reported' '0' '0' '0' '2867' '0' '5224' '0' '54.90%%' '0' '1'

'PY1' 'DPH' 'Santa Clara Valley Medical Center' 'Q-PC2' 'Comprehensive Diabetes Care: Eye Exam (CDC-E)' 'Reported' '0' '0' '0' '2524' '0' '5224' '0' '48.30%%' '0' '1'

'PY1' 'DPH' 'Santa Clara Valley Medical Center' 'Q-PC3' 'Comprehensive Diabetes Care: Blood Pressure Control (CDC-BP)' 'Reported' '0' '0' '0' '3526' '0' '5224' '0' '67.50%%' '0' '1'

'PY1' 'DPH' 'Santa Clara Valley Medical Center' 'Q-PC4' 'Asthma Medication Ratio (AMR)' 'Not Reported' '' '' '' ' ' '' ' ' '' ' ' '' ''

'PY1' 'DPH' 'Santa Clara Valley Medical Center' 'Q-PC5' 'Medication Reconciliation Post Discharge (MRP)' 'Reported' '0' '0' '0' '213' '0' '568' '0' '37.50%%' '0' '1'

'PY1' 'DPH' 'Santa Clara Valley Medical Center' 'Q-PC6' '7 Day Post-Discharge Follow-Up for High Risk Beneficiaries' 'Reported' '0' '0' '0' '137' '0' '1428' '0' '9.60%%' '0' '1'

'PY1' 'DPH' 'Santa Clara Valley Medical Center' 'Q-PC7' 'Children and Adolescent Access to PCP (CAP)' 'Not Reported' '' '' '' '' '' '' '' '' '' ''

'PY1' 'DPH' 'Santa Clara Valley Medical Center' 'Q-PC8' 'Childhood Immunization Status (CIS) Combination 3' 'Reported' '0' '0' '0' '988' '0' '1305' '0' '75.70%%' '0' '1'

'PY1' 'DPH' 'Santa Clara Valley Medical Center' 'Q-PC9' 'Immunization for Adolescents (IMA) Combination 2' 'Reported' '0' '0' '0' '484' '0' '949' '0' '51.00%%' '0' '1'

'PY1' 'DPH' 'Santa Clara Valley Medical Center' 'Q-SC1' 'Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy' 'Reported' '0' '0' '0' '278' '0' '425' '0' '65.40%%' '0' '1'

'PY1' 'DPH' 'Santa Clara Valley Medical Center' 'Q-SC2' 'Coronary Artery Disease (CAD): Antiplatelet Therapy' 'Reported' '0' '0' '0' '1284' '0' '1530' '0' '83.90%%' '0' '1'

'PY1' 'DPH' 'Santa Clara Valley Medical Center' 'Q-SC3' 'Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%%)' 'Reported' '0' '0' '0' '560' '0' '780' '0' '71.80%%' '0' '1'

'PY1' 'DPH' 'Santa Clara Valley Medical Center' 'Q-SC4' 'Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%%)' 'Reported' '0' '0' '0' '158' '0' '447' '0' '35.40%%' '0' '1'

'PY1' 'DPH' 'Santa Clara Valley Medical Center' 'Q-SC5' 'Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction' 'Reported' '0' '0' '0' '0' '0' '0.001' '0' '0.00%%' '0' '1'

'PY1' 'DPH' 'Santa Clara Valley Medical Center' 'Q-SC6' 'Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction' 'Reported' '0' '0' '0' '0' '0' '0.001' '0' '0.00%%' '0' '1'

'PY1' 'DPH' 'Santa Clara Valley Medical Center' 'Q-IP1' 'Surgical Site Infection (SSI) (Reported as SIR)' 'Reported' '0' '0' '0' '13' '0' '12.178' '0' '1.0675' '0' '1'

'PY1' 'DPH' 'Santa Clara Valley Medical Center' 'Q-IP2' 'Perioperative Care: Selection of Prophylactic Antibiotic - 1st OR 2nd Generation Cephalosporin' 'Reported' '0' '0' '0' '971' '0' '1352' '0' '71.80%%' '0' '1'

'PY1' 'DPH' 'Santa Clara Valley Medical Center' 'Q-IP3' 'Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis' 'Reported' '0' '0' '0' '1253' '0' '1304' '0' '96.10%%' '0' '1'

'PY1' 'DPH' 'Santa Clara Valley Medical Center' 'Q-IP4' 'Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections' 'Reported' '0' '0' '0' '93' '0' '791' '0' '11.80%%' '0' '1'

'PY1' 'DPH' 'Santa Clara Valley Medical Center' 'Q-IP5' 'Appropriate Treatment of Methicillin-Sensitive Staphylococcus Aureus (MSSA) Bacteremia' 'Reported' '0' '0' '0' '29' '0' '34' '0' '85.30%%' '0' '1'

'PY1' 'DPH' 'Santa Clara Valley Medical Center' 'Q-IP6' 'Stroke: Discharged on Antithrombotic Therapy (TJC STK-2)' 'Reported' '0' '0' '0' '81' '0' '84' '0' '96.40%%' '0' '1'

'PY1' 'DPH' 'Santa Clara Valley Medical Center' 'Q-RU1' 'Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low Risk Surgery Patients (QPP)' 'Not Reported' '' '' '' '' '' '' '' '' '' ''

'PY1' 'DPH' 'Santa Clara Valley Medical Center' 'Q-RU2' 'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients 18 Years and Older' 'Not Reported' '' '' '' '' '' '' '' '' '' ''

'PY1' 'DPH' 'Santa Clara Valley Medical Center' 'Q-RU3' 'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 to 17 years old' 'Not Reported' '' '' '' '' '' '' '' '' '' ''

'PY1' 'DPH' 'Santa Clara Valley Medical Center' 'Q-RU4' 'Unplanned Reoperation within the 30 Day Postoperative Period (QPP)' 'No Data Entered' '' '' '' '' '' '' '' '' '' ''

'PY1' 'DPH' 'Santa Clara Valley Medical Center' 'Q-RU5' 'Concurrent Use of Opioids and Benzodiazepines' 'Reported' 'N/A' '3' 'N/A' 'N/A' '3' 'N/A' '3' 'N/A' '3' '1'

'PY1' 'DPH' 'Santa Clara Valley Medical Center' 'Q-RU5' '? RATE #1' 'Reported' '0' '0' '0' '122' '0' '1866' '0' '6.50%%' '0' '1'

'PY1' 'DPH' 'Santa Clara Valley Medical Center' 'Q-RU5' '? RATE #2' 'Reported' '0' '0' '0' '145' '0' '2033' '0' '7.10%%' '0' '1'

'PY1' 'DPH' 'San Mateo Medical Center' 'Q-PC1' 'Comprehensive Diabetes Care: A1C Control (<8%%) (CDC-H8)' 'Reported' '0' '0' '0' '1193' '0' '1891' '0' '63.10%%' '0' '1'

'PY1' 'DPH' 'San Mateo Medical Center' 'Q-PC2' 'Comprehensive Diabetes Care: Eye Exam (CDC-E)' 'Reported' '0' '0' '0' '1861' '0' '1891' '0' '98.40%%' '0' '1'

'PY1' 'DPH' 'San Mateo Medical Center' 'Q-PC3' 'Comprehensive Diabetes Care: Blood Pressure Control (CDC-BP)' 'Reported' '0' '0' '0' '1396' '0' '1891' '0' '73.80%%' '0' '1'

'PY1' 'DPH' 'San Mateo Medical Center' 'Q-PC4' 'Asthma Medication Ratio (AMR)' 'Reported' '0' '0' '0' '177' '0' '292' '0' '60.60%%' '0' '1'

'PY1' 'DPH' 'San Mateo Medical Center' 'Q-PC5' 'Medication Reconciliation Post Discharge (MRP)' 'Reported' '0' '0' '0' '288' '0' '598' '0' '48.20%%' '0' '1'

'PY1' 'DPH' 'San Mateo Medical Center' 'Q-PC6' '7 Day Post-Discharge Follow-Up for High Risk Beneficiaries' 'Not Reported' '' '' '' ' ' '' ' ' '' ' ' '' ''

'PY1' 'DPH' 'San Mateo Medical Center' 'Q-PC7' 'Children and Adolescent Access to PCP (CAP)' 'Reported' 'N/A' '3' 'N/A' ' ' '' ' ' '' ' ' '' '1'

'PY1' 'DPH' 'San Mateo Medical Center' 'Q-PC7' '? 12-24 Months' 'Reported' '0' '0' '0' '312' '0' '312' '0' '100.00%%' '0' '1'

'PY1' 'DPH' 'San Mateo Medical Center' 'Q-PC7' '? 25 Months-6 Years' 'Reported' '0' '0' '0' '2008' '0' '2202' '0' '91.20%%' '0' '1'

'PY1' 'DPH' 'San Mateo Medical Center' 'Q-PC7' '? 7-11 Years' 'Reported' '0' '0' '0' '1834' '0' '2147' '0' '85.40%%' '0' '1'

'PY1' 'DPH' 'San Mateo Medical Center' 'Q-PC7' '? 12-19 Years' 'Reported' '0' '0' '0' '2110' '0' '2659' '0' '79.40%%' '0' '1'

'PY1' 'DPH' 'San Mateo Medical Center' 'Q-PC8' 'Childhood Immunization Status (CIS) Combination 3' 'Reported' '0' '0' '0' '190' '0' '281' '0' '67.60%%' '0' '1'

'PY1' 'DPH' 'San Mateo Medical Center' 'Q-PC9' 'Immunization for Adolescents (IMA) Combination 2' 'Reported' '0' '0' '0' '175' '0' '264' '0' '66.30%%' '0' '1'

'PY1' 'DPH' 'San Mateo Medical Center' 'Q-SC1' 'Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy' 'Reported' '0' '0' '0' '301' '0' '397' '0' '75.80%%' '0' '1'

'PY1' 'DPH' 'San Mateo Medical Center' 'Q-SC2' 'Coronary Artery Disease (CAD): Antiplatelet Therapy' 'Reported' '0' '0' '0' '606' '0' '681' '0' '89.00%%' '0' '1'

'PY1' 'DPH' 'San Mateo Medical Center' 'Q-SC3' 'Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%%)' 'Reported' '0' '0' '0' '302' '0' '340' '0' '88.80%%' '0' '1'

'PY1' 'DPH' 'San Mateo Medical Center' 'Q-SC4' 'Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%%)' 'Reported' '0' '0' '0' '143' '0' '159' '0' '89.90%%' '0' '1'

'PY1' 'DPH' 'San Mateo Medical Center' 'Q-SC5' 'Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction' 'Reported' '0' '0' '0' '114' '0' '127' '0' '89.80%%' '0' '1'

'PY1' 'DPH' 'San Mateo Medical Center' 'Q-SC6' 'Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction' 'Reported' '0' '0' '0' '90' '0' '127' '0' '70.90%%' '0' '1'

'PY1' 'DPH' 'San Mateo Medical Center' 'Q-IP1' 'Surgical Site Infection (SSI) (Reported as SIR)' 'Not Reported' '' '' '' ' ' '' ' ' '' ' ' '' ''

'PY1' 'DPH' 'San Mateo Medical Center' 'Q-IP2' 'Perioperative Care: Selection of Prophylactic Antibiotic - 1st OR 2nd Generation Cephalosporin' 'Reported' '0' '0' '0' '218' '0' '226' '0' '96.50%%' '0' '1'

'PY1' 'DPH' 'San Mateo Medical Center' 'Q-IP3' 'Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis' 'Reported' '0' '0' '0' '337' '0' '504' '0' '66.90%%' '0' '1'

'PY1' 'DPH' 'San Mateo Medical Center' 'Q-IP4' 'Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections' 'Reported' '0' '0' '0' '57' '0' '125' '0' '45.60%%' '0' '1'

'PY1' 'DPH' 'San Mateo Medical Center' 'Q-IP5' 'Appropriate Treatment of Methicillin-Sensitive Staphylococcus Aureus (MSSA) Bacteremia' 'Not Reported' '' '' '' ' ' '' ' ' '' ' ' '' ''

'PY1' 'DPH' 'San Mateo Medical Center' 'Q-IP6' 'Stroke: Discharged on Antithrombotic Therapy (TJC STK-2)' 'Not Reported' '' '' '' ' ' '' ' ' '' ' ' '' ''

'PY1' 'DPH' 'San Mateo Medical Center' 'Q-RU1' 'Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low Risk Surgery Patients (QPP)' 'Reported' '0' '0' '0' '' '1' '229' '0' '' '1' '1'

'PY1' 'DPH' 'San Mateo Medical Center' 'Q-RU2' 'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients 18 Years and Older' 'Reported' '0' '0' '0' '63' '0' '78' '0' '80.80%%' '0' '1'

'PY1' 'DPH' 'San Mateo Medical Center' 'Q-RU3' 'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 to 17 years old' 'Not Reported' '' '' '' ' ' '' ' ' '' ' ' '' ''

'PY1' 'DPH' 'San Mateo Medical Center' 'Q-RU4' 'Unplanned Reoperation within the 30 Day Postoperative Period (QPP)' 'Not Reported' '' '' '' '' '' '' '' '' '' ''

'PY1' 'DPH' 'San Mateo Medical Center' 'Q-RU5' 'Concurrent Use of Opioids and Benzodiazepines' 'Reported' 'N/A' '3' 'N/A' 'N/A' '3' 'N/A' '3' 'N/A' '3' '1'

'PY1' 'DPH' 'San Mateo Medical Center' 'Q-RU5' '? RATE #1' 'Reported' '0' '0' '0' '100' '0' '1298' '0' '7.70%%' '0' '1'

'PY1' 'DPH' 'San Mateo Medical Center' 'Q-RU5' '? RATE #2' 'Reported' '0' '0' '0' '167' '0' '1984' '0' '8.40%%' '0' '1'

'PY1' 'DPH' 'UC Davis Medical Center' 'Q-PC1' 'Comprehensive Diabetes Care: A1C Control (<8%%) (CDC-H8)' 'Reported' '0' '0' '0' '0' '0' '0.01' '0' '0.00%%' '0' '1'

'PY1' 'DPH' 'UC Davis Medical Center' 'Q-PC2' 'Comprehensive Diabetes Care: Eye Exam (CDC-E)' 'Reported' '0' '0' '0' '0' '0' '0.01' '0' '0.00%%' '0' '1'

'PY1' 'DPH' 'UC Davis Medical Center' 'Q-PC3' 'Comprehensive Diabetes Care: Blood Pressure Control (CDC-BP)' 'Reported' '0' '0' '0' '0' '0' '0.01' '0' '0.00%%' '0' '1'

'PY1' 'DPH' 'UC Davis Medical Center' 'Q-PC4' 'Asthma Medication Ratio (AMR)' 'Not Reported' '' '' '' ' ' '' ' ' '' ' ' '' ''

'PY1' 'DPH' 'UC Davis Medical Center' 'Q-PC5' 'Medication Reconciliation Post Discharge (MRP)' 'Reported' '0' '0' '0' '34' '0' '44' '0' '77.30%%' '0' '1'

'PY1' 'DPH' 'UC Davis Medical Center' 'Q-PC6' '7 Day Post-Discharge Follow-Up for High Risk Beneficiaries' 'Reported' '0' '0' '0' '49' '0' '58' '0' '84.50%%' '0' '1'

'PY1' 'DPH' 'UC Davis Medical Center' 'Q-PC7' 'Children and Adolescent Access to PCP (CAP)' 'Not Reported' '' '' '' '' '' '' '' '' '' ''

'PY1' 'DPH' 'UC Davis Medical Center' 'Q-PC8' 'Childhood Immunization Status (CIS) Combination 3' 'Not Reported' '' '' '' ' ' '' ' ' '' ' ' '' ''

'PY1' 'DPH' 'UC Davis Medical Center' 'Q-PC9' 'Immunization for Adolescents (IMA) Combination 2' 'Not Reported' '' '' '' '' '' '' '' '' '' ''

'PY1' 'DPH' 'UC Davis Medical Center' 'Q-SC1' 'Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy' 'Reported' '0' '0' '0' '' '1' '' '1' '' '1' '1'

'PY1' 'DPH' 'UC Davis Medical Center' 'Q-SC2' 'Coronary Artery Disease (CAD): Antiplatelet Therapy' 'Reported' '0' '0' '0' '26' '0' '34' '0' '76.50%%' '0' '1'

'PY1' 'DPH' 'UC Davis Medical Center' 'Q-SC3' 'Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%%)' 'Reported' '0' '0' '0' '16' '0' '' '4' '' '4' '1'

'PY1' 'DPH' 'UC Davis Medical Center' 'Q-SC4' 'Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%%)' 'Reported' '0' '0' '0' '13' '0' '' '4' '' '4' '1'

'PY1' 'DPH' 'UC Davis Medical Center' 'Q-SC5' 'Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction' 'Reported' '0' '0' '0' '' '1' '' '1' '' '1' '1'

'PY1' 'DPH' 'UC Davis Medical Center' 'Q-SC6' 'Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction' 'Reported' '0' '0' '0' '' '1' '' '1' '' '1' '1'

'PY1' 'DPH' 'UC Davis Medical Center' 'Q-IP1' 'Surgical Site Infection (SSI) (Reported as SIR)' 'Reported' '0' '0' '0' '29' '0' '31.77' '0' '0.9128' '0' '1'

'PY1' 'DPH' 'UC Davis Medical Center' 'Q-IP2' 'Perioperative Care: Selection of Prophylactic Antibiotic - 1st OR 2nd Generation Cephalosporin' 'Reported' '0' '0' '0' '464' '0' '546' '0' '85.00%%' '0' '1'

'PY1' 'DPH' 'UC Davis Medical Center' 'Q-IP3' 'Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis' 'Reported' '0' '0' '0' '807' '0' '819' '0' '98.50%%' '0' '1'

'PY1' 'DPH' 'UC Davis Medical Center' 'Q-IP4' 'Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections' 'Reported' '0' '0' '0' '143' '0' '269' '0' '53.20%%' '0' '1'

'PY1' 'DPH' 'UC Davis Medical Center' 'Q-IP5' 'Appropriate Treatment of Methicillin-Sensitive Staphylococcus Aureus (MSSA) Bacteremia' 'Reported' '0' '0' '0' '23' '0' '' '4' '' '4' '1'

'PY1' 'DPH' 'UC Davis Medical Center' 'Q-IP6' 'Stroke: Discharged on Antithrombotic Therapy (TJC STK-2)' 'Reported' '0' '0' '0' '37' '0' '37' '0' '100.00%%' '0' '1'

'PY1' 'DPH' 'UC Davis Medical Center' 'Q-RU1' 'Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low Risk Surgery Patients (QPP)' 'Reported' '0' '0' '0' '0' '0' '' '4' '' '4' '1'

'PY1' 'DPH' 'UC Davis Medical Center' 'Q-RU2' 'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients 18 Years and Older' 'Reported' '0' '0' '0' '191' '0' '217' '0' '88.00%%' '0' '1'

'PY1' 'DPH' 'UC Davis Medical Center' 'Q-RU3' 'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 to 17 years old' 'Reported' '0' '0' '0' '14' '0' '113' '0' '12.40%%' '0' '1'

'PY1' 'DPH' 'UC Davis Medical Center' 'Q-RU4' 'Unplanned Reoperation within the 30 Day Postoperative Period (QPP)' 'No Data Entered' '' '' '' '' '' '' '' '' '' ''

'PY1' 'DPH' 'UC Davis Medical Center' 'Q-RU5' 'Concurrent Use of Opioids and Benzodiazepines' 'Not Reported' '' '' '' '' '' '' '' '' '' ''

'PY1' 'DPH' 'UC Irvine Medical Center' 'Q-PC1' 'Comprehensive Diabetes Care: A1C Control (<8%%) (CDC-H8)' 'Reported' '0' '0' '0' '448' '0' '1004' '0' '44.60%%' '0' '1'

'PY1' 'DPH' 'UC Irvine Medical Center' 'Q-PC2' 'Comprehensive Diabetes Care: Eye Exam (CDC-E)' 'Reported' '0' '0' '0' '106' '0' '1004' '0' '10.60%%' '0' '1'

'PY1' 'DPH' 'UC Irvine Medical Center' 'Q-PC3' 'Comprehensive Diabetes Care: Blood Pressure Control (CDC-BP)' 'Reported' '0' '0' '0' '652' '0' '1004' '0' '64.90%%' '0' '1'

'PY1' 'DPH' 'UC Irvine Medical Center' 'Q-PC4' 'Asthma Medication Ratio (AMR)' 'Reported' '0' '0' '0' '32' '0' '63' '0' '50.80%%' '0' '1'

'PY1' 'DPH' 'UC Irvine Medical Center' 'Q-PC5' 'Medication Reconciliation Post Discharge (MRP)' 'Reported' '0' '0' '0' '287' '0' '534' '0' '53.80%%' '0' '1'

'PY1' 'DPH' 'UC Irvine Medical Center' 'Q-PC6' '7 Day Post-Discharge Follow-Up for High Risk Beneficiaries' 'Reported' '0' '0' '0' '31' '0' '77' '0' '40.30%%' '0' '1'

'PY1' 'DPH' 'UC Irvine Medical Center' 'Q-PC7' 'Children and Adolescent Access to PCP (CAP)' 'Reported' 'N/A' '3' 'N/A' '' '' '' '' '' '' '1'

'PY1' 'DPH' 'UC Irvine Medical Center' 'Q-PC7' '? 12-24 Months' 'Reported' '0' '0' '0' '144' '0' '149' '0' '96.60%%' '0' '1'

'PY1' 'DPH' 'UC Irvine Medical Center' 'Q-PC7' '? 25 Months-6 Years' 'Reported' '0' '0' '0' '516' '0' '637' '0' '81.00%%' '0' '1'

'PY1' 'DPH' 'UC Irvine Medical Center' 'Q-PC7' '? 7-11 Years' 'Reported' '0' '0' '0' '545' '0' '646' '0' '84.40%%' '0' '1'

'PY1' 'DPH' 'UC Irvine Medical Center' 'Q-PC7' '? 12-19 Years' 'Reported' '0' '0' '0' '1185' '0' '1431' '0' '82.80%%' '0' '1'

'PY1' 'DPH' 'UC Irvine Medical Center' 'Q-PC8' 'Childhood Immunization Status (CIS) Combination 3' 'Reported' '0' '0' '0' '104' '0' '145' '0' '71.70%%' '0' '1'

'PY1' 'DPH' 'UC Irvine Medical Center' 'Q-PC9' 'Immunization for Adolescents (IMA) Combination 2' 'Not Reported' '' '' '' ' ' '' ' ' '' ' ' '' ''

'PY1' 'DPH' 'UC Irvine Medical Center' 'Q-SC1' 'Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy' 'Reported' '0' '0' '0' '38' '0' '52' '0' '73.10%%' '0' '1'

'PY1' 'DPH' 'UC Irvine Medical Center' 'Q-SC2' 'Coronary Artery Disease (CAD): Antiplatelet Therapy' 'Reported' '0' '0' '0' '205' '0' '259' '0' '79.20%%' '0' '1'

'PY1' 'DPH' 'UC Irvine Medical Center' 'Q-SC3' 'Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%%)' 'Reported' '0' '0' '0' '146' '0' '174' '0' '83.90%%' '0' '1'

'PY1' 'DPH' 'UC Irvine Medical Center' 'Q-SC4' 'Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%%)' 'Not Reported' '' '' '' ' ' '' ' ' '' ' ' '' ''

'PY1' 'DPH' 'UC Irvine Medical Center' 'Q-SC5' 'Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction' 'Reported' '0' '0' '0' '90' '0' '111' '0' '81.10%%' '0' '1'

'PY1' 'DPH' 'UC Irvine Medical Center' 'Q-SC6' 'Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction' 'Reported' '0' '0' '0' '100' '0' '120' '0' '83.30%%' '0' '1'

'PY1' 'DPH' 'UC Irvine Medical Center' 'Q-IP1' 'Surgical Site Infection (SSI) (Reported as SIR)' 'Reported' '0' '0' '0' '26' '0' '25.746' '0' '1.0099' '0' '1'

'PY1' 'DPH' 'UC Irvine Medical Center' 'Q-IP2' 'Perioperative Care: Selection of Prophylactic Antibiotic - 1st OR 2nd Generation Cephalosporin' 'Reported' '0' '0' '0' '764' '0' '1364' '0' '56.00%%' '0' '1'

'PY1' 'DPH' 'UC Irvine Medical Center' 'Q-IP3' 'Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis' 'Reported' '0' '0' '0' '550' '0' '1320' '0' '41.70%%' '0' '1'

'PY1' 'DPH' 'UC Irvine Medical Center' 'Q-IP4' 'Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections' 'Reported' '0' '0' '0' '28' '0' '1093' '0' '2.60%%' '' '1'

'PY1' 'DPH' 'UC Irvine Medical Center' 'Q-IP5' 'Appropriate Treatment of Methicillin-Sensitive Staphylococcus Aureus (MSSA) Bacteremia' 'Reported' '0' '0' '0' '20' '0' '' '4' '' '4' '1'

'PY1' 'DPH' 'UC Irvine Medical Center' 'Q-IP6' 'Stroke: Discharged on Antithrombotic Therapy (TJC STK-2)' 'Reported' '0' '0' '0' '71' '0' '77' '0' '92.20%%' '0' '1'

'PY1' 'DPH' 'UC Irvine Medical Center' 'Q-RU1' 'Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low Risk Surgery Patients (QPP)' 'Not Reported' '' '' '' ' ' '' ' ' '' ' ' '' ''

'PY1' 'DPH' 'UC Irvine Medical Center' 'Q-RU2' 'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients 18 Years and Older' 'Reported' '0' '0' '0' '101' '0' '565' '0' '17.90%%' '0' '1'

'PY1' 'DPH' 'UC Irvine Medical Center' 'Q-RU3' 'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 to 17 years old' 'Reported' '0' '0' '0' '' '1' '68' '0' '' '1' '1'

'PY1' 'DPH' 'UC Irvine Medical Center' 'Q-RU4' 'Unplanned Reoperation within the 30 Day Postoperative Period (QPP)' 'No Data Entered' '' '' '' '' '' '' '' '' '' ''

'PY1' 'DPH' 'UC Irvine Medical Center' 'Q-RU5' 'Concurrent Use of Opioids and Benzodiazepines' 'Reported' 'N/A' '3' 'N/A' 'N/A' '3' 'N/A' '3' 'N/A' '3' '1'

'PY1' 'DPH' 'UC Irvine Medical Center' 'Q-RU5' '? RATE #1' 'Reported' '0' '0' '0' '16' '0' '100' '0' '16.00%%' '0' '1'

'PY1' 'DPH' 'UC Irvine Medical Center' 'Q-RU5' '? RATE #2' 'Reported' '0' '0' '0' '44' '0' '397' '0' '11.10%%' '0' '1'

'PY1' 'DPH' 'UC Los Angeles Medical Center' 'Q-PC1' 'Comprehensive Diabetes Care: A1C Control (<8%%) (CDC-H8)' 'Reported' '0' '0' '0' '52' '0' '92' '0' '56.50%%' '0' '1'

'PY1' 'DPH' 'UC Los Angeles Medical Center' 'Q-PC2' 'Comprehensive Diabetes Care: Eye Exam (CDC-E)' 'Reported' '0' '0' '0' '33' '0' '92' '0' '35.90%%' '0' '1'

'PY1' 'DPH' 'UC Los Angeles Medical Center' 'Q-PC3' 'Comprehensive Diabetes Care: Blood Pressure Control (CDC-BP)' 'Reported' '0' '0' '0' '68' '0' '92' '0' '73.90%%' '0' '1'

'PY1' 'DPH' 'UC Los Angeles Medical Center' 'Q-PC4' 'Asthma Medication Ratio (AMR)' 'Reported' '0' '0' '0' '12' '0' '' '4' '' '4' '1'

'PY1' 'DPH' 'UC Los Angeles Medical Center' 'Q-PC5' 'Medication Reconciliation Post Discharge (MRP)' 'Reported' '0' '0' '0' '69' '0' '99' '0' '69.70%%' '0' '1'

'PY1' 'DPH' 'UC Los Angeles Medical Center' 'Q-PC6' '7 Day Post-Discharge Follow-Up for High Risk Beneficiaries' 'Reported' '0' '0' '0' '' '1' '' '4' '' '1' '1'

'PY1' 'DPH' 'UC Los Angeles Medical Center' 'Q-PC7' 'Children and Adolescent Access to PCP (CAP)' 'Reported' 'N/A' '3' 'N/A' '' '' '' '' '' '' '1'

'PY1' 'DPH' 'UC Los Angeles Medical Center' 'Q-PC7' '? 12-24 Months' 'Reported' '0' '0' '0' '163' '0' '168' '0' '97.00%%' '0' '1'

'PY1' 'DPH' 'UC Los Angeles Medical Center' 'Q-PC7' '? 25 Months-6 Years' 'Reported' '0' '0' '0' '903' '0' '1068' '0' '84.60%%' '0' '1'

'PY1' 'DPH' 'UC Los Angeles Medical Center' 'Q-PC7' '? 7-11 Years' 'Reported' '0' '0' '0' '691' '0' '779' '0' '88.70%%' '0' '1'

'PY1' 'DPH' 'UC Los Angeles Medical Center' 'Q-PC7' '? 12-19 Years' 'Reported' '0' '0' '0' '932' '0' '1035' '0' '90.10%%' '0' '1'

'PY1' 'DPH' 'UC Los Angeles Medical Center' 'Q-PC8' 'Childhood Immunization Status (CIS) Combination 3' 'Reported' '0' '0' '0' '100' '0' '149' '0' '67.10%%' '0' '1'

'PY1' 'DPH' 'UC Los Angeles Medical Center' 'Q-PC9' 'Immunization for Adolescents (IMA) Combination 2' 'Reported' '0' '0' '0' '33' '0' '109' '0' '30.30%%' '0' '1'

'PY1' 'DPH' 'UC Los Angeles Medical Center' 'Q-SC1' 'Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy' 'Reported' '0' '0' '0' '' '1' '' '1' '' '1' '1'

'PY1' 'DPH' 'UC Los Angeles Medical Center' 'Q-SC2' 'Coronary Artery Disease (CAD): Antiplatelet Therapy' 'Reported' '0' '0' '0' '26' '0' '38' '0' '68.40%%' '0' '1'

'PY1' 'DPH' 'UC Los Angeles Medical Center' 'Q-SC3' 'Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%%)' 'Reported' '0' '0' '0' '13' '0' '' '4' '' '4' '1'

'PY1' 'DPH' 'UC Los Angeles Medical Center' 'Q-SC4' 'Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%%)' 'Reported' '0' '0' '0' '17' '0' '' '4' '' '4' '1'

'PY1' 'DPH' 'UC Los Angeles Medical Center' 'Q-SC5' 'Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction' 'Reported' '0' '0' '0' '' '1' '' '4' '' '1' '1'

'PY1' 'DPH' 'UC Los Angeles Medical Center' 'Q-SC6' 'Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction' 'Reported' '0' '0' '0' '' '1' '' '4' '' '1' '1'

'PY1' 'DPH' 'UC Los Angeles Medical Center' 'Q-IP1' 'Surgical Site Infection (SSI) (Reported as SIR)' 'Reported' '0' '0' '0' '22' '0' '25.993' '0' '0.8464' '0' '1'

'PY1' 'DPH' 'UC Los Angeles Medical Center' 'Q-IP2' 'Perioperative Care: Selection of Prophylactic Antibiotic - 1st OR 2nd Generation Cephalosporin' 'Reported' '0' '0' '0' '607' '0' '752' '0' '80.70%%' '0' '1'

'PY1' 'DPH' 'UC Los Angeles Medical Center' 'Q-IP3' 'Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis' 'Reported' '0' '0' '0' '1118' '0' '1198' '0' '93.30%%' '0' '1'

'PY1' 'DPH' 'UC Los Angeles Medical Center' 'Q-IP4' 'Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections' 'Reported' '0' '0' '0' '346' '0' '1507' '0' '23.00%%' '0' '1'

'PY1' 'DPH' 'UC Los Angeles Medical Center' 'Q-IP5' 'Appropriate Treatment of Methicillin-Sensitive Staphylococcus Aureus (MSSA) Bacteremia' 'Reported' '0' '0' '0' '30' '0' '41' '0' '73.20%%' '0' '1'

'PY1' 'DPH' 'UC Los Angeles Medical Center' 'Q-IP6' 'Stroke: Discharged on Antithrombotic Therapy (TJC STK-2)' 'Reported' '0' '0' '0' '60' '0' '60' '0' '100.00%%' '0' '1'

'PY1' 'DPH' 'UC Los Angeles Medical Center' 'Q-RU1' 'Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low Risk Surgery Patients (QPP)' 'Reported' '0' '0' '0' '' '1' '32' '0' '' '1' '1'

'PY1' 'DPH' 'UC Los Angeles Medical Center' 'Q-RU2' 'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients 18 Years and Older' 'Reported' '0' '0' '0' '268' '0' '292' '0' '91.80%%' '0' '1'

'PY1' 'DPH' 'UC Los Angeles Medical Center' 'Q-RU3' 'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 to 17 years old' 'Reported' '0' '0' '0' '0' '0' '46' '0' '0.00%%' '0' '1'

'PY1' 'DPH' 'UC Los Angeles Medical Center' 'Q-RU4' 'Unplanned Reoperation within the 30 Day Postoperative Period (QPP)' 'No Data Entered' '' '' '' '' '' '' '' '' '' ''

'PY1' 'DPH' 'UC Los Angeles Medical Center' 'Q-RU5' 'Concurrent Use of Opioids and Benzodiazepines' 'Reported' 'N/A' '3' 'N/A' 'N/A' '3' 'N/A' '3' 'N/A' '3' '1'

'PY1' 'DPH' 'UC Los Angeles Medical Center' 'Q-RU5' '? RATE #1' 'Reported' '0' '0' '0' '' '1' '31' '0' '' '1' '1'

'PY1' 'DPH' 'UC Los Angeles Medical Center' 'Q-RU5' '? RATE #2' 'Reported' '0' '0' '0' '' '1' '62' '0' '' '1' '1'

'PY1' 'DPH' 'UC San Diego Medical Center' 'Q-PC1' 'Comprehensive Diabetes Care: A1C Control (<8%%) (CDC-H8)' 'Reported' '0' '0' '0' '265' '0' '384' '0' '69.00%%' '0' '1'

'PY1' 'DPH' 'UC San Diego Medical Center' 'Q-PC2' 'Comprehensive Diabetes Care: Eye Exam (CDC-E)' 'Reported' '0' '0' '0' '221' '0' '384' '0' '57.60%%' '0' '1'

'PY1' 'DPH' 'UC San Diego Medical Center' 'Q-PC3' 'Comprehensive Diabetes Care: Blood Pressure Control (CDC-BP)' 'Reported' '0' '0' '0' '268' '0' '384' '0' '69.80%%' '0' '1'

'PY1' 'DPH' 'UC San Diego Medical Center' 'Q-PC4' 'Asthma Medication Ratio (AMR)' 'Reported' '0' '0' '0' '46' '0' '63' '0' '73.00%%' '0' '1'

'PY1' 'DPH' 'UC San Diego Medical Center' 'Q-PC5' 'Medication Reconciliation Post Discharge (MRP)' 'Reported' '0' '0' '0' '205' '0' '333' '0' '61.60%%' '0' '1'

'PY1' 'DPH' 'UC San Diego Medical Center' 'Q-PC6' '7 Day Post-Discharge Follow-Up for High Risk Beneficiaries' 'Reported' '0' '0' '0' '20' '0' '44' '0' '45.50%%' '0' '1'

'PY1' 'DPH' 'UC San Diego Medical Center' 'Q-PC7' 'Children and Adolescent Access to PCP (CAP)' 'Reported' 'N/A' '3' 'N/A' '' '' '' '' '' '' '1'

'PY1' 'DPH' 'UC San Diego Medical Center' 'Q-PC7' '? 12-24 Months' 'Reported' '0' '0' '0' '0' '0' '0.001' '0' '0.00%%' '0' '1'

'PY1' 'DPH' 'UC San Diego Medical Center' 'Q-PC7' '? 25 Months-6 Years' 'Reported' '0' '0' '0' '12' '0' '' '4' '' '4' '1'

'PY1' 'DPH' 'UC San Diego Medical Center' 'Q-PC7' '? 7-11 Years' 'Reported' '0' '0' '0' '' '1' '' '1' '' '1' '1'

'PY1' 'DPH' 'UC San Diego Medical Center' 'Q-PC7' '? 12-19 Years' 'Reported' '0' '0' '0' '' '1' '' '1' '' '1' '1'

'PY1' 'DPH' 'UC San Diego Medical Center' 'Q-PC8' 'Childhood Immunization Status (CIS) Combination 3' 'Reported' '0' '0' '0' '0' '0' '0.001' '0' '0.00%%' '0' '1'

'PY1' 'DPH' 'UC San Diego Medical Center' 'Q-PC9' 'Immunization for Adolescents (IMA) Combination 2' 'Reported' '0' '0' '0' '0' '0' '0.001' '0' '0.00%%' '0' '1'

'PY1' 'DPH' 'UC San Diego Medical Center' 'Q-SC1' 'Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy' 'Reported' '0' '0' '0' '50' '0' '54' '0' '92.60%%' '0' '1'

'PY1' 'DPH' 'UC San Diego Medical Center' 'Q-SC2' 'Coronary Artery Disease (CAD): Antiplatelet Therapy' 'Reported' '0' '0' '0' '196' '0' '233' '0' '84.10%%' '0' '1'

'PY1' 'DPH' 'UC San Diego Medical Center' 'Q-SC3' 'Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%%)' 'Reported' '0' '0' '0' '70' '0' '107' '0' '65.40%%' '0' '1'

'PY1' 'DPH' 'UC San Diego Medical Center' 'Q-SC4' 'Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%%)' 'Reported' '0' '0' '0' '47' '0' '62' '0' '75.80%%' '0' '1'

'PY1' 'DPH' 'UC San Diego Medical Center' 'Q-SC5' 'Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction' 'Reported' '0' '0' '0' '30' '0' '36' '0' '83.30%%' '0' '1'

'PY1' 'DPH' 'UC San Diego Medical Center' 'Q-SC6' 'Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction' 'Reported' '0' '0' '0' '34' '0' '36' '0' '94.40%%' '0' '1'

'PY1' 'DPH' 'UC San Diego Medical Center' 'Q-IP1' 'Surgical Site Infection (SSI) (Reported as SIR)' 'Reported' '0' '0' '0' '55' '0' '37.797' '0' '1.4551' '0' '1'

'PY1' 'DPH' 'UC San Diego Medical Center' 'Q-IP2' 'Perioperative Care: Selection of Prophylactic Antibiotic - 1st OR 2nd Generation Cephalosporin' 'Reported' '0' '0' '0' '771' '0' '1247' '0' '61.80%%' '0' '1'

'PY1' 'DPH' 'UC San Diego Medical Center' 'Q-IP3' 'Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis' 'Reported' '0' '0' '0' '628' '0' '1022' '0' '61.50%%' '0' '1'

'PY1' 'DPH' 'UC San Diego Medical Center' 'Q-IP4' 'Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections' 'Reported' '0' '0' '0' '630' '0' '1583' '0' '39.80%%' '0' '1'

'PY1' 'DPH' 'UC San Diego Medical Center' 'Q-IP5' 'Appropriate Treatment of Methicillin-Sensitive Staphylococcus Aureus (MSSA) Bacteremia' 'Reported' '0' '0' '0' '16' '0' '' '4' '' '4' '1'

'PY1' 'DPH' 'UC San Diego Medical Center' 'Q-IP6' 'Stroke: Discharged on Antithrombotic Therapy (TJC STK-2)' 'Reported' '0' '0' '0' '51' '0' '52' '0' '98.10%%' '0' '1'

'PY1' 'DPH' 'UC San Diego Medical Center' 'Q-RU1' 'Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low Risk Surgery Patients (QPP)' 'Reported' '0' '0' '0' '' '1' '39' '0' '' '1' '1'

'PY1' 'DPH' 'UC San Diego Medical Center' 'Q-RU2' 'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients 18 Years and Older' 'Reported' '0' '0' '0' '0' '0' '0.001' '0' '0.00%%' '0' '1'

'PY1' 'DPH' 'UC San Diego Medical Center' 'Q-RU3' 'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 to 17 years old' 'Reported' '0' '0' '0' '0' '0' '0.001' '0' '0.00%%' '0' '1'

'PY1' 'DPH' 'UC San Diego Medical Center' 'Q-RU4' 'Unplanned Reoperation within the 30 Day Postoperative Period (QPP)' 'No Data Entered' '' '' '' '' '' '' '' '' '' ''

'PY1' 'DPH' 'UC San Diego Medical Center' 'Q-RU5' 'Concurrent Use of Opioids and Benzodiazepines' 'Reported' 'N/A' '3' 'N/A' 'N/A' '3' 'N/A' '3' 'N/A' '3' '1'

'PY1' 'DPH' 'UC San Diego Medical Center' 'Q-RU5' '? RATE #1' 'Reported' '0' '0' '0' '22' '0' '' '4' '' '4' '1'

'PY1' 'DPH' 'UC San Diego Medical Center' 'Q-RU5' '? RATE #2' 'Reported' '0' '0' '0' '27' '0' '37' '0' '73.00%%' '0' '1'

'PY1' 'DPH' 'UC San Francisco Medical Center' 'Q-PC1' 'Comprehensive Diabetes Care: A1C Control (<8%%) (CDC-H8)' 'Reported' '0' '0' '0' '387' '0' '708' '0' '54.70%%' '0' '1'

'PY1' 'DPH' 'UC San Francisco Medical Center' 'Q-PC2' 'Comprehensive Diabetes Care: Eye Exam (CDC-E)' 'Reported' '0' '0' '0' '465' '0' '708' '0' '65.70%%' '0' '1'

'PY1' 'DPH' 'UC San Francisco Medical Center' 'Q-PC3' 'Comprehensive Diabetes Care: Blood Pressure Control (CDC-BP)' 'Reported' '0' '0' '0' '468' '0' '708' '0' '66.10%%' '0' '1'

'PY1' 'DPH' 'UC San Francisco Medical Center' 'Q-PC4' 'Asthma Medication Ratio (AMR)' 'Reported' '0' '0' '0' '95' '0' '182' '0' '52.20%%' '0' '1'

'PY1' 'DPH' 'UC San Francisco Medical Center' 'Q-PC5' 'Medication Reconciliation Post Discharge (MRP)' 'Reported' '0' '0' '0' '263' '0' '540' '0' '48.70%%' '0' '1'

'PY1' 'DPH' 'UC San Francisco Medical Center' 'Q-PC6' '7 Day Post-Discharge Follow-Up for High Risk Beneficiaries' 'Reported' '0' '0' '0' '62' '0' '103' '0' '60.20%%' '0' '1'

'PY1' 'DPH' 'UC San Francisco Medical Center' 'Q-PC7' 'Children and Adolescent Access to PCP (CAP)' 'Reported' 'N/A' '3' 'N/A' '' '' '' '' '' '' '1'

'PY1' 'DPH' 'UC San Francisco Medical Center' 'Q-PC7' '? 12-24 Months' 'Reported' '0' '0' '0' '135' '0' '147' '0' '91.80%%' '0' '1'

'PY1' 'DPH' 'UC San Francisco Medical Center' 'Q-PC7' '? 25 Months-6 Years' 'Reported' '0' '0' '0' '1148' '0' '1427' '0' '80.50%%' '0' '1'

'PY1' 'DPH' 'UC San Francisco Medical Center' 'Q-PC7' '? 7-11 Years' 'Reported' '0' '0' '0' '858' '0' '990' '0' '86.70%%' '0' '1'

'PY1' 'DPH' 'UC San Francisco Medical Center' 'Q-PC7' '? 12-19 Years' 'Reported' '0' '0' '0' '1071' '0' '1211' '0' '88.40%%' '0' '1'

'PY1' 'DPH' 'UC San Francisco Medical Center' 'Q-PC8' 'Childhood Immunization Status (CIS) Combination 3' 'Reported' '0' '0' '0' '186' '0' '231' '0' '80.50%%' '0' '1'

'PY1' 'DPH' 'UC San Francisco Medical Center' 'Q-PC9' 'Immunization for Adolescents (IMA) Combination 2' 'Reported' '0' '0' '0' '63' '0' '136' '0' '46.30%%' '0' '1'

'PY1' 'DPH' 'UC San Francisco Medical Center' 'Q-SC1' 'Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy' 'Reported' '0' '0' '0' '27' '0' '31' '0' '87.10%%' '0' '1'

'PY1' 'DPH' 'UC San Francisco Medical Center' 'Q-SC2' 'Coronary Artery Disease (CAD): Antiplatelet Therapy' 'Reported' '0' '0' '0' '114' '0' '127' '0' '89.80%%' '0' '1'

'PY1' 'DPH' 'UC San Francisco Medical Center' 'Q-SC3' 'Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%%)' 'Reported' '0' '0' '0' '43' '0' '61' '0' '70.50%%' '0' '1'

'PY1' 'DPH' 'UC San Francisco Medical Center' 'Q-SC4' 'Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%%)' 'Reported' '0' '0' '0' '33' '0' '42' '0' '78.60%%' '0' '1'

'PY1' 'DPH' 'UC San Francisco Medical Center' 'Q-SC5' 'Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction' 'Reported' '0' '0' '0' '33' '0' '40' '0' '82.50%%' '0' '1'

'PY1' 'DPH' 'UC San Francisco Medical Center' 'Q-SC6' 'Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction' 'Reported' '0' '0' '0' '27' '0' '40' '0' '67.50%%' '0' '1'

'PY1' 'DPH' 'UC San Francisco Medical Center' 'Q-IP1' 'Surgical Site Infection (SSI) (Reported as SIR)' 'Reported' '0' '0' '0' '47' '0' '53.335' '0' '0.8812' '0' '1'

'PY1' 'DPH' 'UC San Francisco Medical Center' 'Q-IP2' 'Perioperative Care: Selection of Prophylactic Antibiotic - 1st OR 2nd Generation Cephalosporin' 'Reported' '0' '0' '0' '6049' '0' '9320' '0' '64.90%%' '0' '1'

'PY1' 'DPH' 'UC San Francisco Medical Center' 'Q-IP3' 'Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis' 'Reported' '0' '0' '0' '3543' '0' '3906' '0' '90.70%%' '0' '1'

'PY1' 'DPH' 'UC San Francisco Medical Center' 'Q-IP4' 'Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections' 'Reported' '0' '0' '0' '27' '0' '1698' '0' '1.60%%' '0' '1'

'PY1' 'DPH' 'UC San Francisco Medical Center' 'Q-IP5' 'Appropriate Treatment of Methicillin-Sensitive Staphylococcus Aureus (MSSA) Bacteremia' 'Reported' '0' '0' '0' '32' '0' '62' '0' '51.60%%' '0' '1'

'PY1' 'DPH' 'UC San Francisco Medical Center' 'Q-IP6' 'Stroke: Discharged on Antithrombotic Therapy (TJC STK-2)' 'Reported' '0' '0' '0' '48' '0' '57' '0' '84.20%%' '0' '1'

'PY1' 'DPH' 'UC San Francisco Medical Center' 'Q-RU1' 'Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low Risk Surgery Patients (QPP)' 'Reported' '0' '0' '0' '18' '0' '215' '0' '8.40%%' '0' '1'

'PY1' 'DPH' 'UC San Francisco Medical Center' 'Q-RU2' 'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients 18 Years and Older' 'Reported' '0' '0' '0' '76' '0' '177' '0' '42.90%%' '0' '1'

'PY1' 'DPH' 'UC San Francisco Medical Center' 'Q-RU3' 'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 to 17 years old' 'Reported' '0' '0' '0' '' '1' '' '4' '' '1' '1'

'PY1' 'DPH' 'UC San Francisco Medical Center' 'Q-RU4' 'Unplanned Reoperation within the 30 Day Postoperative Period (QPP)' 'Reported' '0' '0' '0' '19' '0' '686' '0' '2.80%%' '0' '1'

'PY1' 'DPH' 'UC San Francisco Medical Center' 'Q-RU5' 'Concurrent Use of Opioids and Benzodiazepines' 'Reported' 'N/A' '3' 'N/A' 'N/A' '3' 'N/A' '3' 'N/A' '3' '1'

'PY1' 'DPH' 'UC San Francisco Medical Center' 'Q-RU5' '? RATE #1' 'Reported' '0' '0' '0' '82' '0' '556' '0' '14.80%%' '0' '1'

'PY1' 'DPH' 'UC San Francisco Medical Center' 'Q-RU5' '? RATE #2' 'Reported' '0' '0' '0' '110' '0' '805' '0' '13.70%%' '0' '1'

'PY1' 'DPH' 'Ventura County Medical Center' 'Q-PC1' 'Comprehensive Diabetes Care: A1C Control (<8%%) (CDC-H8)' 'Reported' '0' '0' '0' '1632' '0' '2729' '0' '59.80%%' '0' '1'

'PY1' 'DPH' 'Ventura County Medical Center' 'Q-PC2' 'Comprehensive Diabetes Care: Eye Exam (CDC-E)' 'Reported' '0' '0' '0' '1164' '0' '2729' '0' '42.70%%' '0' '1'

'PY1' 'DPH' 'Ventura County Medical Center' 'Q-PC3' 'Comprehensive Diabetes Care: Blood Pressure Control (CDC-BP)' 'Reported' '0' '0' '0' '2024' '0' '2729' '0' '74.20%%' '0' '1'

'PY1' 'DPH' 'Ventura County Medical Center' 'Q-PC4' 'Asthma Medication Ratio (AMR)' 'Reported' '0' '0' '0' '681' '0' '1355' '0' '50.30%%' '0' '1'

'PY1' 'DPH' 'Ventura County Medical Center' 'Q-PC5' 'Medication Reconciliation Post Discharge (MRP)' 'Not Reported' '' '' '' ' ' '' ' ' '' ' ' '' ''

'PY1' 'DPH' 'Ventura County Medical Center' 'Q-PC6' '7 Day Post-Discharge Follow-Up for High Risk Beneficiaries' 'Reported' '0' '0' '0' '226' '0' '479' '0' '47.20%%' '0' '1'

'PY1' 'DPH' 'Ventura County Medical Center' 'Q-PC7' 'Children and Adolescent Access to PCP (CAP)' 'Reported' 'N/A' '3' 'N/A' '' '' '' '' '' '' '1'

'PY1' 'DPH' 'Ventura County Medical Center' 'Q-PC7' '? 12-24 Months' 'Reported' '0' '0' '0' '1718' '0' '1831' '0' '93.80%%' '0' '1'

'PY1' 'DPH' 'Ventura County Medical Center' 'Q-PC7' '? 25 Months-6 Years' 'Reported' '0' '0' '0' '6174' '0' '7310' '0' '84.50%%' '0' '1'

'PY1' 'DPH' 'Ventura County Medical Center' 'Q-PC7' '? 7-11 Years' 'Reported' '0' '0' '0' '6345' '0' '7726' '0' '82.10%%' '0' '1'

'PY1' 'DPH' 'Ventura County Medical Center' 'Q-PC7' '? 12-19 Years' 'Reported' '0' '0' '0' '7293' '0' '9285' '0' '78.60%%' '0' '1'

'PY1' 'DPH' 'Ventura County Medical Center' 'Q-PC8' 'Childhood Immunization Status (CIS) Combination 3' 'Reported' '0' '0' '0' '1189' '0' '1488' '0' '79.90%%' '0' '1'

'PY1' 'DPH' 'Ventura County Medical Center' 'Q-PC9' 'Immunization for Adolescents (IMA) Combination 2' 'Reported' '0' '0' '0' '319' '0' '943' '0' '33.80%%' '0' '1'

'PY1' 'DPH' 'Ventura County Medical Center' 'Q-SC1' 'Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy' 'Reported' '0' '0' '0' '87' '0' '119' '0' '73.10%%' '0' '1'

'PY1' 'DPH' 'Ventura County Medical Center' 'Q-SC2' 'Coronary Artery Disease (CAD): Antiplatelet Therapy' 'Reported' '0' '0' '0' '415' '0' '486' '0' '85.40%%' '0' '1'

'PY1' 'DPH' 'Ventura County Medical Center' 'Q-SC3' 'Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%%)' 'Reported' '0' '0' '0' '200' '0' '246' '0' '81.30%%' '0' '1'

'PY1' 'DPH' 'Ventura County Medical Center' 'Q-SC4' 'Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%%)' 'Reported' '0' '0' '0' '58' '0' '67' '0' '86.60%%' '0' '1'

'PY1' 'DPH' 'Ventura County Medical Center' 'Q-SC5' 'Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction' 'Reported' '0' '0' '0' '66' '0' '74' '0' '89.20%%' '0' '1'

'PY1' 'DPH' 'Ventura County Medical Center' 'Q-SC6' 'Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction' 'Reported' '0' '0' '0' '67' '0' '73' '0' '91.80%%' '0' '1'

'PY1' 'DPH' 'Ventura County Medical Center' 'Q-IP1' 'Surgical Site Infection (SSI) (Reported as SIR)' 'Reported' '0' '0' '0' '' '1' '6.399' '0' '' '1' '1'

'PY1' 'DPH' 'Ventura County Medical Center' 'Q-IP2' 'Perioperative Care: Selection of Prophylactic Antibiotic - 1st OR 2nd Generation Cephalosporin' 'Reported' '0' '0' '0' '777' '0' '947' '0' '82.10%%' '0' '1'

'PY1' 'DPH' 'Ventura County Medical Center' 'Q-IP3' 'Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis' 'Reported' '0' '0' '0' '1004' '0' '1054' '0' '95.30%%' '0' '1'

'PY1' 'DPH' 'Ventura County Medical Center' 'Q-IP4' 'Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections' 'Reported' '0' '0' '0' '0' '0' '310' '0' '0.00%%' '0' '1'

'PY1' 'DPH' 'Ventura County Medical Center' 'Q-IP5' 'Appropriate Treatment of Methicillin-Sensitive Staphylococcus Aureus (MSSA) Bacteremia' 'Not Reported' '' '' '' '' '' '' '' '' '' ''

'PY1' 'DPH' 'Ventura County Medical Center' 'Q-IP6' 'Stroke: Discharged on Antithrombotic Therapy (TJC STK-2)' 'Not Reported' '' '' '' '' '' '' '' '' '' ''

'PY1' 'DPH' 'Ventura County Medical Center' 'Q-RU1' 'Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low Risk Surgery Patients (QPP)' 'Reported' '0' '0' '0' '' '1' '175' '0' '' '1' '1'

'PY1' 'DPH' 'Ventura County Medical Center' 'Q-RU2' 'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients 18 Years and Older' 'Reported' '0' '0' '0' '82' '0' '133' '0' '61.70%%' '0' '1'

'PY1' 'DPH' 'Ventura County Medical Center' 'Q-RU3' 'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 to 17 years old' 'Not Reported' '' '' '' ' ' '' ' ' '' ' ' '' ''

'PY1' 'DPH' 'Ventura County Medical Center' 'Q-RU4' 'Unplanned Reoperation within the 30 Day Postoperative Period (QPP)' 'No Data Entered' '' '' '' '' '' '' '' '' '' ''

'PY1' 'DPH' 'Ventura County Medical Center' 'Q-RU5' 'Concurrent Use of Opioids and Benzodiazepines' 'Not Reported' '' '' '' '' '' '' '' '' '' ''